10-Q/A

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q/A

(Amendment No. 1)

xQuarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the quarterly period ended September 30, 2013

Or

oTransition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the transition period from to

Commission file number 001-33404

URANIUM RESOURCES, INC.

(Exact Name of Issuer as Specified in Its Charter)

DELAWARE	75-2212772
(State of Incorporation)	(I.R.S. Employer Identification No.)

6950 S. Potomac Street, Suite 300, Centennial, Colorado 80112

(Address of Principal Executive Offices, Including Zip Code)

(303) 531-0470

(Issuer’s Telephone Number, Including Area Code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer o	Accelerated filer o
Non-accelerated filer o	Smaller reporting company x
(Do not check if a smaller reporting company)

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12-b2 of the Exchange Act). Yes o No x

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

Title of Each Class of Common Stock	Number of Shares Outstanding
Common Stock, $0.001 par value	19,820,258 as of October 28, 2013

Explanatory Note

As previously disclosed in a Current Report on Form 8-K filed on November 19, 2013, Uranium Resources, Inc. (the “Company,” “URI,” “we,” “us” or “our”) historically capitalized development costs after confirmation of the existence of a commercially minable uranium deposit. After discussions with the Staff of the United States Securities and Exchange Commission (the “SEC”), URI management determined that the Company’s capitalization practices were not in conformance with the SEC’s Industry Guide 7, which allows capitalization of development costs only after proven or probable reserves have been declared.

This Amendment No. 1 on Form 10-Q/A (the “Amendment” or “Form 10-Q/A”) amends and restates the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2013, as originally filed with the SEC on October 28, 2013 (the “Original Form 10-Q”). This Amendment amends and restates the Company’s consolidated financial statements and related disclosures as of September 30, 2013 and for the three and nine months ended September 30, 2013 and 2012 by reclassifying costs from property, plant and equipment to mineral property expenses. The impact of the restatement is more fully described in Note 3 to the consolidated financial statements contained in this Amendment. Concurrently with the filing of this Amendment, the Company is also filing Amendment No. 1 to its Annual Report on Form 10-K for the year ended December 31, 2012 to amend and restate the Company’s consolidated financial statements and related disclosures as of December 31, 2011 and 2012 and for the years ended December 31, 2010, 2011 and 2012. As a result of the restatement, management has re-evaluated and amended its conclusions regarding the Company’s disclosure controls and procedures and internal control over financial reporting as contained in Item 4 of Part I.

In addition, URI management has also determined, consistent with Industry Guide 7, to disclose mineralized material in terms of tons and grade only in its filings with the SEC. Accordingly, the Company will no longer disclose pounds of mineralized uranium material contained in the ground, and this Amendment removes all such disclosure. This Amendment also corrects an error in the number of shares of common stock outstanding as of  September 30, 2013, as reflected in the consolidated financial statements contained in this Amendment, and as of October 28, 2013, as shown on the cover page. The correct number is 19,820,258 shares, as indicated in the consolidated financial statements and on the cover page of this Amendment.

The following items of the Original Form 10-Q have been modified or revised in this Form 10-Q/A to reflect the restatement and other changes identified above:

·the cover page;

·Part I, Item 1. “Financial Statements”;

·Part I, Item 2. “Management’s Discussion and Analysis of Financial Condition and Results of Operations”; and

·Part I, Item 4. “Controls and Procedures”.

The Company’s principal executive officer and principal financial officer have also provided currently dated certifications pursuant to Sections 302 and 906 of the Sarbanes-Oxley Act of 2002 in connection with this Amendment.

This Amendment sets forth the Original Form 10-Q in its entirety, except as required to reflect the effects of the restatement and other changes identified above. Except for disclosures affected by the restatement and other changes, this Amendment speaks as of the original filing date of the Original Form 10-Q and does not modify or update other disclosures in the Original Form 10-Q, including the nature and character of such disclosures, to reflect events occurring or items discovered after the original filing date of the Original Form 10-Q.

This Amendment should be read in conjunction with the Company’s amended Annual Report on Form 10-K/A for the year ended December 31, 2012 and all filings made with the SEC subsequent to the original filing date of the Form 10-K, together with any amendments to those filings, including the Company’s amended Quarterly Reports on Form 10-Q/A for the quarterly periods ended March 31, 2013 and June 30, 2013, as filed with the SEC on December 17, 2013.

URANIUM RESOURCES, INC.

2013 THIRD QUARTERLY REPORT ON FORM 10-Q

TABLE OF CONTENTS

PART I—FINANCIAL INFORMATION
	Item 1.	Financial Statements
		Condensed Consolidated Balance Sheets- September 30, 2013 and December 31, 2012 (Unaudited)	3
		Condensed Consolidated Statements of Operations—three and nine months ended September 30, 2013 and 2012 (Unaudited)	4
		Condensed Consolidated Statements of Cash Flows—nine months ended September 30, 2013 and 2012 (Unaudited)	5
		Notes to Condensed Consolidated Financial Statements—September 30, 2013 (Unaudited)	6
	Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	13
	Item 3.	Quantitative and Qualitative Disclosures About Market Risk	19
	Item 4.	Controls and Procedures	19
PART II—OTHER INFORMATION			20
	Item 1.	Legal Proceedings	20
	Item 1A.	Risk Factors	20
	Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	21
	Item 3.	Defaults Upon Senior Securities	21
	Item 4.	Mine Safety Disclosure	22
	Item 5.	Other Information	22
	Item 6.	Exhibits	22
SIGNATURES			23
Index to Exhibits			E-1

2

PART I — FINANCIAL INFORMATION

ITEM 1.  FINANCIAL STATEMENTS

Uranium Resources, Inc.

Condensed Consolidated Balance Sheets

(Unaudited)

	September 30,			December 31,
	2013			2012
	(Restated)			(Restated)
ASSETS
Current Assets:
Cash and cash equivalents	$	2,006,833		$	4,664,596
Prepaid and other current assets	466,970			708,228
Total Current Assets	2,473,803			5,372,824
Property, plant and equipment, at cost:
Property, plant and equipment	99,891,946			100,058,667
Less accumulated depreciation, depletion and impairment	(65,544,841		)	(65,318,921		)
Net property, plant and equipment	34,347,105			34,739,746
Certificates of deposit, restricted	4,010,850			9,491,865
Total Assets	$	40,831,758		$	49,604,435
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current Liabilities:
Accounts payable	$	397,479		$	1,331,888
Accrued liabilities	1,840,951			1,525,726
Note payable	—			5,000,000
Current portion of asset retirement obligations	502,472			1,160,378
Current portion of capital leases	19,861			112,140
Total Current Liabilities	2,760,763			9,130,132
Asset retirement obligations	3,602,252			3,337,679
Long-term debt	950,000			950,000
Long-term capital leases, less current portion	6,688			17,582
Total Liabilities	7,319,703			13,435,393
Shareholders’ Equity:
Common stock, 200,000,000 shares authorized, $.001 par value; 19,820,258 and 16,150,163 shares issued and outstanding, respectively	19,824			16,154
Paid-in capital	216,620,930			207,338,549
Accumulated deficit	(183,119,281		)	(171,176,243		)
Less: Treasury stock (3,813 shares), at cost	(9,418		)	(9,418		)
Total Shareholders’ Equity	33,512,055			36,169,042
Total Liabilities and Shareholders’ Equity	$	40,831,758		$	49,604,435

Commitments and contingencies (Note 10)

The accompanying notes are an integral part of these condensed consolidated financial statements.

3

Uranium Resources, Inc.

Condensed Consolidated Statements of Operations

(Unaudited)

	Three Months Ended						Nine Months Ended
	September 30,						September 30,
	2013			2012			2013			2012
	(Restated)			(Restated)			(Restated)			(Restated)
Revenues:	$	—		$	—		$	—		$	—
Cost of uranium sales:
Operating expenses	568,033			776,764			1,886,157			1,920,601
Mineral property expenses	371,984			981,657			1,796,313			3,215,697
Accretion/amortization of asset retirement obligations	97,435			22,673			292,305			69,416
Depreciation and depletion	76,089			91,319			225,907			318,637
Impairment of uranium properties	3,701			296,628			683,356			1,048,400
Total cost of uranium sales	1,117,242			2,169,041			4,884,038			6,572,751
Loss from operations before corporate expenses	(1,117,242		)	(2,169,041		)	(4,884,038		)	(6,572,751		)
Corporate expenses:
General and administrative	2,174,862			2,994,663			6,749,980			8,191,352
Depreciation	32,631			40,911			115,773			104,751
Total corporate expenses	2,207,493			3,035,574			6,865,753			8,296,103
Loss from operations	(3,324,735		)	(5,204,615		)	(11,749,791		)	(14,868,854		)
Other income and expense:
Interest expense	(3,859		)	(6,055		)	(253,485		)	(12,723		)
Interest and other income, net	55,703			20,501			60,238			247,678
Net loss	$	(3,272,891	)	$	(5,190,169	)	$	(11,943,038	)	$	(14,633,899	)
Basic and diluted net loss per common share	$	(0.16	)	$	(0.42	)	$	(0.63	)	$	(1.34	)
Average weighted shares outstanding	19,820,258			12,413,476			18,995,957			10,953,407

The accompanying notes are an integral part of these condensed consolidated financial statements.

4

Uranium Resources, Inc.

Condensed Consolidated Statements of Cash Flows

(Unaudited)

	Nine Months Ended
	September 30,
	2013			2012
	(Restated)			(Restated)
Operating activities:
Net loss	$	(11,943,038	)	$	(14,633,899	)
Reconciliation of net loss to cash used in operations:
Accretion/amortization of asset retirement obligations	292,305			69,416
Depreciation and depletion	341,680			423,388
Impairment of uranium properties	683,356			1,048,400
Decrease in restoration and reclamation accrual	(1,269,663		)	(1,299,806		)
Stock compensation expense	299,286			373,838
Other non-cash items, net	73,875			73,932
Effect of changes in operating working capital items:
(Increase) decrease in receivables	258,532			(140,228		)
Increase in prepaid and other current assets	(17,274		)	(125,058		)
Increase (decrease) in payables, accrued liabilities and deferred credits	(231,931		)	668,089
Net cash used in operating activities	(11,512,872		)	(13,541,928		)
Cash flows from investing activities:
Decrease in certificates of deposit, restricted	5,481,015			167,855
Additions to uranium properties	(122,165		)	(1,132,294		)
Acquisition of Neutron Energy, Inc.	—			(3,677,133		)
Net cash provided by (used in) investing activities	5,358,850			(4,641,572		)
Cash flows from financing activities:
Payments on borrowings	(103,173		)	(56,775		)
Issuance of common stock, net	3,599,432			19,328,360
Net cash provided by financing activities	3,496,259			19,271,585
Net increase (decrease) in cash and cash equivalents	(2,657,763		)	1,088,085
Cash and cash equivalents, beginning of period	4,664,596			2,890,263
Cash and cash equivalents, end of period	$	2,006,833		$	3,978,348
Non-cash transactions:
Issuance of common stock for short term loan principal and interest payment	$	5,095,833		$	—
Issuance of common stock for services	$	291,500		$	—
Issuance of restricted stock to employees and directors	$	47		$	391
Issuance of common stock to acquire Neutron Energy, Inc.	$	—		$	16,650,000
Capital lease obligations	$	—		$	106,154

The accompanying notes are an integral part of these condensed consolidated financial statements.

5

Uranium Resources, Inc.

Notes to Condensed Consolidated Financial Statements September 30, 2013

(Unaudited)

1. DESCRIPTION OF BUSINESS

Uranium Resources, Inc. (URI) is a uranium exploration, development and production company. We were organized in 1977 to acquire and develop uranium mines in South Texas using the in-situ recovery mining process (ISR). URI has historically produced uranium by ISR methods in the State of Texas where the Company currently has ISR mining projects, including two licensed processing facilities. We also have mineral holdings in New Mexico and a NRC license to produce up to 3 million pounds per annum of uranium on certain of our New Mexico projects. The Company acquired these properties over the past 20 years along with an extensive information database of historic mining logs and analysis. None of URI’s properties are currently in production.

2. BASIS OF PRESENTATION

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements. The accompanying statements should be read in conjunction with the audited financial statements included in the Company’s 2012 Annual Report on Form 10-K/A. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the nine months ended September 30, 2013 are not necessarily indicative of the results that may be expected for any other period including the full year ending December 31, 2013.

3. RESTATEMENT

The Company determined that the capitalization of development costs primarily on its New Mexico mineral properties and to a lesser extent on its South Texas mineral properties was not in accordance with U.S. GAAP.  As a result, the Company has amended and restated its consolidated financial statements for the years ended December 31, 2012, 2011 and 2010, to reflect a cumulative adjustment to mineral property expenditures of $8,974,000 up to December 31, 2012.  These adjustments to property expenditures were previously capitalized as property, plant and equipment.

The Company has also restated the March 31, 2013 and June 30, 2013 interim condensed consolidated financial statements to expense certain costs previously capitalized as mineral property development costs. The Company has determined that its capitalization of these expenditures was not in accordance with U.S. GAAP.  As a result, the Company has amended and restated the interim condensed consolidated balance sheet as of September 30, 2013 to expense $762,000 of costs incurred during the nine-months ended September 30, 2013 that were previously capitalized as development costs to mineral property expenses, and reverse impairment costs recorded in the amount of $766,000.  The interim condensed consolidated statements of operations for the nine-month periods ended September 30, 2013 and 2012 were amended and restated to expense $762,000 and $3,146,000, respectively, of costs previously capitalized as development costs to mineral property expenses, and reverse impairment costs recorded during the nine-months ended September 30, 2013 in the amount of $766,000.  Corresponding changes were made to the interim statements of cash flows for the nine-months ended September 30, 2013 and 2012.

Consolidated Balance Sheet

	September 30, 2013
	As Reported		Adjustment		As Restated
	$		$		$
Assets
Property, plant and equipment	108,862,877		(8,970,931	)	99,891,946
Total Assets	49,802,689		(8,970,931	)	40,831,758
Shareholders’ equity
Accumulated deficit	(174,148,350	)	(8,970,931	)	(183,119,281	)
Total shareholders’ equity	42,482,986		(8,970,931	)	33,512,055
Total liabilities and shareholders’ equity	49,802,689		(8,970,931	)	40,831,758

6

Consolidated Statement of Operations

	Three Months Ended September 30, 2013
	As Reported		Adjustment		As Restated
	$		$		$
Mineral property expenses	282,478		89,506		371,984
Impairment of uranium properties	769,580		(765,879	)	3,701
Total cost of uranium sales	1,793,615		(676,373	)	1,117,242
Loss from operations before corporate expenses	(1,793,615	)	676,373		(1,117,242	)
Loss from operations	(4,001,108	)	676,373		(3,324,735	)
Net loss	(3,949,264	)	676,373		(3,272,891	)
Basic and diluted net loss per common share	(0.20	)	0.04		(0.16	)

Consolidated Statement of Operations

	Nine Months Ended September 30, 2013
	As Reported		Adjustment		As Restated
	$		$		$
Mineral property expenses	1,033,838		762,475		1,796,313
Impairment of uranium properties	1,449,235		(765,879	)	683,356
Total cost of uranium sales	4,887,442		(3,404	)	4,884,038
Loss from operations before corporate expenses	(4,887,442	)	3,404		(4,884,038	)
Loss from operations	(11,753,195	)	3,404		(11,749,791	)
Net loss	(11,946,442	)	3,404		(11,943,038	)
Basic and diluted net loss per common share	(0.63	)	0.00		(0.63	)

Consolidated Statement of Cash Flows

	Nine Months Ended September 30, 2013
	As Reported		Adjustment		As Restated
	$		$		$
Net loss	(11,946,442	)	3,404		(11,943,038	)
Impairment of uranium properties	1,449,235		(765,879	)	683,356
Additions to uranium properties	(884,640	)	762,475		(122,165	)

Consolidated Statement of Operations

	Three Months Ended September 30, 2012
	As Reported		Adjustment		As Restated
	$		$		$
Mineral property expenses	12,402		969,255		981,657
Total cost of uranium sales	1,199,786		969,255		2,169,041
Loss from operations before corporate expenses	(1,199,786	)	(969,255	)	(2,169,041	)
Loss from operations	(4,235,360	)	(969,255	)	(5,204,615	)
Net loss	(4,220,914	)	(969,255	)	(5,190,169	)
Basic and diluted net loss per common share	(0.34	)	(0.08	)	(0.42	)

Consolidated Statement of Operations

	Nine Months Ended September 30, 2012
	As Reported		Adjustment		As Restated
	$		$		$
Mineral property expenses	69,861		3,145,836		3,215,697
Total cost of uranium sales	3,426,915		3,145,836		6,572,751
Loss from operations before corporate expenses	(3,426,915	)	(3,145,836	)	(6,572,751	)
Loss from operations	(11,723,018	)	(3,145,836	)	(14,868,854	)
Net loss	(11,488,063	)	(3,145,836	)	(14,633,899	)
Basic and diluted net loss per common share	(1.05	)	(0.29	)	(1.34	)

Consolidated Statement of Cash Flows

	Nine Months Ended September 30, 2012
	As Reported		Adjustment		As Restated
	$		$		$
Net loss	(11,488,063	)	(3,145,836	)	(14,633,899	)
Additions to uranium properties	(4,278,130	)	3,145,836		(1,132,294	)

7

4. LIQUIDITY AND GOING CONCERN

The Company had negative cash flow from operations of $11.5 million for the nine months ended September 30, 2013. Our cash position was $2.0 million at September 30, 2013. The Company is not currently commercially producing uranium and, as such, does not anticipate generating any significant sales revenues in 2013.

In March 2013, the Company completed a Shareholder Rights Offering (“Rights Offering”) in the amount of $8.6 million, whereby the Company received $3.6 million in cash, net of expenses and $5.0 million was used to repay the short term financing from its largest shareholder, Resource Capital Fund V L.P. (“RCF”). RCF owns approximately 32.8% of the Company’s common stock.

In February 2013, the Company secured a new source to satisfy its financial surety obligations for the Texas regulatory agencies. Previously, the Company had met its financial surety obligations through a combination of bank issued letters of credit (the “L/Cs”) and bonds issued for the benefit of the Company. These financial surety arrangements required the Company to fully collateralize the face amount of the L/C’s and the bonds with short term investment vehicles. This requirement resulted in the Company posting $9.3 million in cash that was restricted for the purpose of collateralizing these obligations. The Company’s new financial surety arrangements are provided by Lexon Insurance Company (“Lexon”) in the form of bonds issued for the benefit of the Company. The amount of the bonds written by Lexon total approximately $9.0 million and the collateral requirements of these bonds requires the Company to maintain 40% of the value of the bonds in the form of restricted cash. This change in collateral requirement occurred in April 2013 and reduced the amount of restricted cash required by the Company to $3.6 million and resulted in a corresponding increase in cash to the Company of $5.4 million.

In the fourth quarter of 2011, the Company entered into an At-The-Market Sales Agreement with BTIG, LLC, allowing the Company to sell from time to time its common shares having an aggregate offering price of up to $15.0 million, through an “at-the-market” equity offering program (“ATM Sales Agreement”). The Company did not make any sales under the ATM Sales Agreement in the third quarter of 2013 and has a total of $9.0 million available for future sales under the ATM Sales Agreement.

After careful consideration of a variety of financing options, on October 14, 2013, the Company and RCF entered into a non-binding letter agreement (the “Letter Agreement”) whereby RCF agreed, subject to the terms and conditions set forth in the Letter Agreement, to provide a secured convertible loan facility of up to $15.0 million to the Company (the “Facility”). RCF’s investment committee approved the Facility on October 17, 2013, subject to a number of conditions precedent and the terms and conditions in the Letter Agreement. The Facility would provide the Company with $3.0 million upon closing, which is expected on or before November 15, 2013, another $2 million would be available upon stockholder approval, which is expected to occur on or before January 31, 2014, and two additional tranches of $5.0 million each would be available in 2014 at the election of the Company.

There can be no assurance that the Facility will be available on or before November 15, 2013 or that the Facility will be completed on the terms contemplated or on other terms. As of October 21, 2013, the Company had a cash balance of approximately $1.3 million. On average, the Company has been expending approximately $1.3 million of cash per month during the first nine months of 2013 and expects to spend $1.1 million per month during the balance of 2013. If adequate funds are not available through the Facility, the Company will need to seek alternative sources of debt or equity capital and to the extent that the Company raises additional capital through the sale of equity or convertible debt securities, the issuance of such securities may result in substantial dilution to existing stockholders. There can be no assurance that the Company will be able to obtain additional capital if the Facility does not close, that the terms of alternative capital would not be less favorable to the Company or that such additional capital could be obtained on a timely basis, if at all. If additional capital is not available in sufficient amounts or on a timely basis, the Company will experience liquidity problems in the near future, and the Company could face the need to significantly curtail current operations, change planned business strategies and pursue other remedial measures.

The Company’s condensed consolidated interim financial statements have been prepared assuming that the Company will continue as a going concern; however, should the Company be unsuccessful in closing the financing transaction with RCF discussed above, it would raise substantial doubt about the Company’s ability to do so. The condensed consolidated interim financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result should the Company be unable to continue as a going concern.

8

5. PROPERTY, PLANT AND EQUIPMENT

Certain of the balances presented below have been restated as described in Note 3:

	Property, Plant and
	Equipment, net at:
	9/30/2013		12/31/2012
	(Restated)		(Restated)
Uranium plant	$	9,451,000	$	9,532,000
Permits and licenses	174,000		174,000
Mineral rights and properties	20,874,000		20,872,000
Evaluation and delineation	2,022,000		2,022,000
Vehicles/depreciable equipment	1,230,000		1,435,000
Other property, plant and equipment	596,000		705,000
Total	$	34,347,000	$	34,740,000

Impairment of Uranium Properties

The Company shut-in production at certain of its South Texas properties in 2009.  The Company reviews the estimated cost of restoration and remediation activities on these particular mineral properties at each quarter end.  For any increase in estimated cost, the Company initially records the change on its balance sheet by increasing the mineral property asset and increasing the asset retirement obligation in accordance with U.S. generally accepted accounting principles (ASC 410-20-35-8).  However, because there is no further production expected from these particular South Texas properties, the increase in costs recorded to the mineral property asset are then expensed as impairment expense on the statement of operations.

For the nine months ended September 30, 2013 and 2012, as a result of the accounting procedure described above, and the write-offs described above, the Company recorded impairment costs in the amount of approximately $683,000 and $1,048,000, respectively.  The impairment provision for the three months ended September 30, 2013 was $4,000, compared to $297,000 for the corresponding period in 2012.

6. SHAREHOLDERS’ EQUITY

Reverse Stock Split

Immediately following the close of trading on January 22, 2013, the Company completed a 1 for 10 reverse stock split for its common stock. With the reverse stock split, every ten shares of the Company’s issued and outstanding common stock were combined into one issued and outstanding share of common stock. The reverse stock split had no effect on the par value of the shares or the authorized number of shares of the Company. The reverse split reduced the number of URI’s outstanding common stock from approximately 161.1 million shares to approximately 16.1 million shares. All share data herein has been retroactively adjusted for the reverse stock split as of December 31, 2012.

The following table details the changes in shareholders’ equity for the nine months ended September 30, 2013:

9

	Common Stock			Paid-In			Accumulated			Treasury
	Shares	Amount		Capital			Deficit			Stock
							(Restated)
Balances, December 31, 2012, as reported	16,150,163	$	16,154	$	207,338,549		$	(162,201,908	)	$	(9,418	)
Prior period adjustment	—	—		—			(8,974,335		)	—
Balances, December 31, 2012, as restated	16,150,163	$	16,154	$	207,338,549		$	(171,176,243	)	$	(9,418	)
Net loss, restated	—	—		—			(11,943,038		)
Stock compensation expense	—	—		299,286			—			—
Common stock issued - payment of loan principal and interest services	1,992,127	1,992		5,093,841			—			—
Common stock issued - shareholder rights offering	1,547,843	1,548		3,597,884			—			—
Common stock issued for services	83,200	83		291,417			—			—
Restricted stock issuance	46,925	47		(47		)	—			—
Balances, September 30, 2013, as restated	19,820,258	$	19,824	$	216,620,930		$	(183,119,281	)	$	(9,418	)

See Note 7 - Stock Based Compensation for further discussion of stock compensation expense and restricted stock issuance.

Equity Infusion—Shareholder Rights Offering

In March 2013, the Company completed the Rights Offering, whereby each URI shareholder and warrant holder received one non-transferrable subscription right for each share of common stock owned or subject to a warrant as of 5:00pm ET on January 28, 2013. Every subscription right entitled the holder to purchase 0.3119 of a share of common stock of URI at a price of $2.55 per whole share.

Under the Rights Offering, the Company raised $3.6 million in cash, net of expenses and $5.0 million was used to repay the short term financing from RCF, whereby RCF was issued 1.96 million shares of the Company’s common stock. Also in connection with the RCF short term financing, the Company issued 31,343 shares of common stock in 2013 to pay fourth quarter 2012 and first quarter 2013 interest accrued on the loan of $16,667 and $79,167, respectively.

7. STOCK BASED COMPENSATION

Our stock based compensation programs consist of stock option and restricted stock grants made to employees and directors.

2013 Omnibus Incentive Plan

In June 2013, the Company’s stockholders and Board approved the 2013 Omnibus Incentive Plan (“2013 OIP”) that governs all future share-based awards. A total of approximately 1 million shares are available to be issued under the 2013 OIP.

Stock Compensation Expense

Stock compensation expense for the nine months ended September 30, 2013 and 2012 was $299,000 and $374,000, respectively. Stock compensation expense is recorded as a component of general and administrative expenses for each period. The Company did not recognize a tax benefit from the stock compensation expense because the Company considers it is more likely than not that the related deferred tax assets, which have been reduced by a full valuation allowance, will not be realized.

On January 16, 2013, the Company granted to a newly appointed non-employee director stock options to purchase 5,000 common shares of the Company. The fair value for this issuance was $3.30.

On March 12, 2013, the Company granted 25,000 restricted shares of the Company’s common stock to the new President and Chief Executive Officer, subject to service and performance vesting criteria over a three-year period. The fair value for this issuance was $2.73.

On March 12, 2013, the Company also granted to the new President and Chief Executive Officer stock options to purchase 55,000 common shares of the Company, subject to service and performance vesting criteria over a three-year period. The fair value for this issuance was $1.98.

10

On March 12, 2013, the Company granted 25,000 restricted shares of the Company’s common stock to a former executive of the Company in connection with a separation agreement signed with the executive. The Company recognized stock compensation expense for the restricted share grants of $43,000 in the first half of 2013 in connection with this issuance. In addition, the Company extended the exercise period for certain previously issued stock options for this former executive and recognized stock compensation expense for this modification of $134,000 in the first half of 2013.

On June 4, 2013, the Compensation Committee approved a grant of 100,000 shares of restricted stock units under the 2013 OIP to the President and Chief Executive Officer, subject to specific vesting criteria over a three-year period. The fair value for this issuance was $2.83.

On June 4, 2013, the Board also approved a grant of a total of 100,000 restricted stock units under the 2013 OIP to the Company’s non-employee Directors, subject to specific vesting criteria over a three-year period. The fair value for this issuance was $2.83.

On July 30, 2013, the Compensation Committee approved a grant of 80,000 shares of restricted stock units under the 2013 OIP to the Vice President-Finance and Chief Financial Officer, subject to specific vesting criteria over a three-year period. The fair value for this issuance was $4.50.

The fair value of stock options granted to employees and directors was estimated on the dates of the grants using the Black-Sholes option pricing model with the following assumptions used for the grants made during the period:

Risk free rate	1.40% - 2.16%
Expected life	5.7 — 7.8 years
Expected volatility	84% - 89%
Expected dividend yield	0.0%

The total estimated unrecognized compensation cost from the unvested stock options and restricted grants at September 30, 2013 was approximately $1,058,000, which is expected to be recognized over the weighted average vesting period of the individual grants which range from 1-3 years.

Stock Options for the Nine Months Ended September 30, 2013

The following table summarizes stock options outstanding and changes during the nine-month period ended September 30, 2013:

	Outstanding Options
	Number of Shares		Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (Years)	Aggregate Intrinsic Value
Options outstanding at January 1, 2013	317,270		$	24.62
Granted	60,000		2.85
Exercised	—		—
Canceled or forfeited	(72,791	)	25.90
Options outstanding at September 30,2013	304,479		$	20.02	4.1	$	—
Options exercisable at September 30, 2013	226,980		$	25.57	2.3	$	—

Shares available for grant under the Company’s stock option plans as of September 30, 2013 were 907,914.

Stock options outstanding and currently exercisable at September 30, 2013 are as follows:

	Outstanding Options				Options Exercisable
Stock Option Plan	Number of Options Outstanding	Weighted Average Remaining Contractual Life (in years)	Weighted Average Exercise Price		Number of Options Exercisable	Weighted Average Exercise Price
1995 Stock Incentive Plan	145,906	0.9	$	13.46	145,906	$	13.46
2004 Stock Incentive Plan	85,241	7.8	13.92		29,408	34.74
2004 Director’s Plan	73,332	6.1	40.19		51,666	54.57
	304,479	4.1	$	20.02	226,980	$	25.57

11

8. ASSET RETIREMENT OBLIGATIONS

The following table shows the change in the balance of the restoration and reclamation liability during the nine months ended September 30, 2013:

Reserve for future restoration and reclamation costs, beginning of year	$	4,498,057
Additions and changes in cash flow estimates	584,025
Costs incurred	(1,269,663		)
Accretion expense	292,305
Reserve for future restoration and reclamation costs, end of period	$	4,104,724

9. EARNINGS PER SHARE

The basic earnings per share calculation includes no dilution and is computed by dividing income or loss attributed to common stockholders by the weighted-average number of common shares outstanding for the period. The diluted earnings per share reflects the potential dilution that could occur if stock options and warrants were exercised or converted into common stock. Potentially dilutive shares of 426,841 were excluded from the calculation of earnings per share because they were anti-dilutive due to our net loss position for the nine months ended September 30, 2013.

10. COMMITMENTS AND CONTINGENCIES

In July 2013, the Company amended its uranium supply contract with Itochu Corporation (“Itochu”) to include a new sales pricing structure, new delivery dates and quantity levels. Pursuant to the amended agreement, Itochu would purchase one-half of all production from the Company’s Vasquez, Rosita or Kingsville properties up to three million pounds of U3O8. Any new production outside of those areas is not subject to the agreement. The purchase price will be based on published market prices at the time of delivery subject to a five percent discount when the market price is $56.50 per pound of U3O8 or less, or seven percent when greater than $56.50 per pound.

The Company’s mining operations are subject to federal and state regulations for the protection of the environment, including water quality regulations. These laws periodically change and generally become more restrictive. The ongoing costs of complying with such regulations have not been significant to the Company’s annual operating costs. Future mine closure and reclamation costs are provided for as each pound of uranium is produced on a unit-of-production basis. The Company reviews its reclamation obligations each year and determines the appropriate unit charge. The Company also evaluates the status of current environmental laws and their potential impact on their accrual for costs. The Company believes its operations are in compliance with current environmental regulations.

The Company is from time to time involved in various legal proceedings of a character normally incident to its business. Management believes it has meritorious defenses in all such proceedings and is not aware of any material adverse effect on the Company’s financial condition or results of operations from such proceedings.

Registration Statements

In connection with our May 2008 private placement and the March 2012 investment agreement with RCF, the Company executed registration rights agreements pursuant to which the shares issued in the private placement and under the investment agreement were registered. The registration rights agreements provide for penalties in the event the registration statements fail to remain effective. At September 30, 2013, the Company’s registration statements were and remain effective.

Employment Agreements

The Company has entered into employment agreements with the certain of the Executive Officers of the Company that provide that, in the event of a change in control, such officers will have certain rights and benefits for a period of twenty-four months following such change in control. The employment agreements provide that the executive’s base salary payments shall be made on a monthly basis for the duration of the term and any incentive payments shall be paid annually until the obligation to make such payments expires.

In March 2013, the Company entered into an Employment Agreement with the Company’s new President and Chief Executive Officer with a one-year term (subject to subsequent automatic one-year renewals). In the event his employment is terminated following a change in control, he would be entitled to two year’s base salary payable in a lump sum within 30 days after his termination date. In the event the Company terminates the Employment Agreement during its term, other than for cause or elects not to renew the Employment Agreement at the conclusion of its term, he would be entitled to one year’s base salary payable in a lump sum within 30 days after his termination date.

12

In June 2013, the Company entered into an Employment Agreement with the Company’s new Vice President — Finance and Chief Financial Officer with a one-year term (subject to subsequent automatic one-year renewals).  In the event his employment is terminated following a change in control, he would be entitled to one year’s base salary payable in a lump sum within 30 days after his termination date. In the event the Company terminates the Employment Agreement during its term, other than for cause or elects not to renew the Employment Agreement at the conclusion of its terms, he would be entitled to six month’s base salary payable in a lump sum within 30 days after his termination date.

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Forward Looking Statements

This Quarterly Report on Form 10-Q/A contains “forward-looking statements” that involve risks and uncertainties that could cause actual results to differ materially from projections or estimates contained herein. These statements include, without limitation, statements relating to liquidity, financing of operations, the outcome of regulatory actions and litigation, continued volatility of uranium prices and other matters. The words “believes,” “expects,” “projects,” “targets,” “estimates” or similar expressions identify forward-looking statements. Forward-looking statements convey our current expectations or forecasts of future events. We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995. We do not undertake to update, revise or correct any of the forward-looking information, except as required by law. Readers are cautioned not to put undue reliance on forward-looking statements. Forward-looking statements should be read in conjunction with our disclosures and the risks set forth herein and in the Company’s 2012 Annual Report on Form 10-K/A under the caption “Risk Factors.”

Restatement and Revision of Previously Reported Consolidated Financial Information

This Item 2 has been amended and restated to give effect to the restatement of our previously issued consolidated financial statements and related disclosures as of December 31, 2011 and 2012 and for the years ended December 31, 2010, 2011 and 2012, and our unaudited condensed consolidated financial statements for each of the quarters within 2012 and 2013. The Company historically capitalized development costs after confirmation of the existence of a commercially minable uranium deposit. After discussions with the Staff of the SEC, URI management determined that the Company’s capitalization practices were not in conformance with the SEC’s Industry Guide 7, which allows capitalization of development costs only after proven or probable reserves have been declared. This Amendment amends and restates the Company’s consolidated financial statements by reclassifying costs from property, plant and equipment to mineral property expenses. The impact of the restatement is more fully described in Note 3 to the condensed consolidated financial statements contained elsewhere in this quarterly report.

General

The Company’s vision is to be a leading U.S. uranium developer and producer. Our strategy is to create wealth for shareholders by advancing our projects in a way which both conserves cash and best positions us to return to production when uranium markets improve. In Texas, our focus is to add quality reserves within an economic distance of each licensed ISR processing facility through exploration activities and/or through value accretive acquisitions. In New Mexico, we will continue to progress the Churchrock Section 8 ISR project and also assess the potential of our significant resource base for the development of larger scale projects on a standalone basis or with partners.

We have 206,600 acres of mineral holdings in New Mexico and a NRC license to produce up to 3 million pounds per annum of uranium on certain of our New Mexico projects. The Company acquired these properties over the past 20 years along with an extensive information database of historic mining logs and analysis. None of URI’s properties are currently in production.

Recent Developments

SEC Comment Letters

In connection with a routine review of our Exchange Act reports by the staff of the SEC’s Division of Corporation Finance (the “Staff”), we have received letters from the Staff setting forth comments and questions with respect to our originally filed Annual Report on Form 10-K for the year ended December 31, 2012 (the “Comment Letters”) and the Company has submitted responses to such letters. Among other things, the Comment Letters have questioned the capitalization of certain costs (primarily in connection with land holding, physical plant and permits) relating to projects without reserves defined as proven and probable in accordance with the SEC’s Industry Guide 7, and the Company’s practices in regards to testing assets for impairment. The Staff has also questioned the disclosure of pounds of U3O8 for non-mineralized resources when Industry Guide 7 permits the disclosure of mineralized materials

13

only in terms of tons and grade. We have been corresponding with the Staff with regard to these matters and a resolution has not been reached at this time. See Part II, Item 1A—Risk Factors, “We have received comments letters from the Staff of the SEC which may require us to restate our historical financial statements” for additional information about the Comment Letters.

RCF Letter Agreement

After careful consideration of a variety of funding options, on October 14, 2013, the Company and its largest stockholder, Resource Capital Fund V L.P. (“RCF”) entered into a non-binding letter agreement (the “Letter Agreement”) whereby RCF agreed, subject to certain terms and conditions, to provide a secured convertible loan facility of up to $15.0 million to the Company (the “Facility”). RCF’s investment committee approved this Facility on October 17, 2013, subject to certain terms and conditions.

RCF’s commitment and investment committee approval to enter into the Facility is subject to numerous terms and conditions, including, among others, preparation and execution of definitive documentation, completion of due diligence satisfactory to RCF and stockholder approval of the Facility. Notwithstanding the absence of stockholder approval, a $3.0 million advance would be available to the Company following the closing of the Facility, which is expected to occur on or before November 15, 2013. Another $2 million would be available upon stockholder approval, which is expected to occur on or before January 31, 2014. Two additional tranches of $5.0 million each would be available in 2014 at the election of the Company. The Facility would be guaranteed by the Company’s subsidiaries and secured by substantially all of the Company’s assets.

Financial Condition and Results of Operations

Comparison of Three and Nine Months Ended September 30, 2013 and 2012

Uranium Sales

During the first nine months of 2013 and 2012, we had no uranium sales.

Cost of Uranium Sales

The costs incurred in the first nine months of 2013 and 2012 for operations and depreciation/depletion resulted from stand-by, maintenance and monitoring activities at our Rosita, Kingsville Dome, and Vasquez projects. Our total cost of uranium sales is comprised of production costs, including operating expenses, depreciation and depletion expenses, and also includes amortization of our restoration and reclamation cost estimates, exploration costs incurred during the period and impairment provisions for uranium properties.

The following table details our cost of uranium sales breakdown for the three and nine months ended September 30, 2013 and 2012:

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2013		2012		2013		2012
Total pounds sold	—		—		—		—
Total operating expenses	$	568,000	$	777,000	$	1,886,000	$	1,921,000
Depreciation and depletion	76,000		91,000		226,000		319,000
Direct cost of sales	$	644,000	$	868,000	$	2,112,000	$	2,240,000

Operating Expenses

During the first nine months of 2013, we incurred total operating expenses of $1,886,000, of which $421,000 was connected with our South Texas projects and $1,465,000 with the Kingsville Dome pond recovery project. During the first nine months of 2012, we incurred operating expenses of $1,141,000 related to our South Texas projects and $780,000 in connection with the Kingsville Dome pond recovery project.

During the three months ended September 30, 2013, we incurred total operating expenses of $568,000, of which $137,000 was connected with our South Texas projects and $431,000 with the Kingsville Dome pond recovery project. During the three months ended September 30, 2012, we incurred operating expenses of $526,000 related to our South Texas projects and $251,000 in connection with the Kingsville Dome pond recovery project.

Mineral Property Expenses

For the three-months ended September 30, 2013 and 2012 we incurred mineral property expenses of $372,000 and $982,000, respectively, which were primarily for the Company’s New Mexico properties.  For the three-months ended September 30, 2013, these costs were primarily for permitting costs on the Churchrock, Crownpoint and Juan Tafoya properties ($90,000) and exploration costs

14

on other properties ($282,000).  For the three-months ended September 30, 2012, these costs were primarily for land holding costs on the Churchrock and West Largo properties ($351,000), plant and wellfield development costs on the Churchrock property ($190,000), permitting costs on the Churchrock, Crownpoint, Cebolleta and Juan Tafoya properties ($429,000) and exploration costs on other properties ($12,000) .

During the first nine-months of 2013 and 2012 we incurred mineral property expenses of $1,796,000 and $3,216,000, respectively, which were primarily for the Company’s New Mexico properties.  For the nine months ended September 30, 2013, these costs were primarily for land holding costs on the Elizabeth, Roca Honda, Mesa Redonda, Hogan and West Endy properties ($376,000), permitting costs on the Churchrock, Crownpoint, Cebolleta and Juan Tafoya properties ($386,000) and exploration costs on other properties ($1,034,000).  For the nine-months ended September 30, 2012, these costs were primarily for land holding costs on the Churchrock and West Largo properties and the Marshall property in Texas ($1,083,000), plant and wellfield development costs on the Churchrock property ($1,394,000), permitting costs on the Churchrock, Crownpoint, Cebolleta and Juan Tafoya properties ($670,000) and exploration costs on other properties ($70,000).

Depreciation and Depletion

During the first nine months of 2013 and 2012, we incurred depreciation and depletion expense related to our South Texas projects of $226,000 and $319,000, respectively. During the three months ended September 30, 2013, we incurred depreciation and depletion expense related to our South Texas projects of $76,000, compared to $91,000 for the corresponding period in 2012. All such costs were from stand-by and/or care and maintenance activities.

Impairment of Uranium Properties

The Company shut-in production at certain of its South Texas properties in 2009.  The Company reviews the estimated cost of restoration and remediation activities on these particular mineral properties at each quarter end.  For any change in estimated cost, the Company initially records the change on its Balance Sheet by increasing or decreasing the mineral property asset and increasing or decreasing the asset retirement obligation in accordance with U.S. generally accepted accounting principles (ASC 410-20-35-8).  However, because there is no further production expected from these particular South Texas properties, the increase or decrease in costs recorded to the mineral property asset are then expensed (or credited) as impairment expense on the Statement of Operations.

For the nine months ended September 30, 2013 and 2012, as a result of the accounting procedure described above, and the write-offs described above, the Company recorded impairment costs in the amount of approximately $683,000 and $1,048,000, respectively.  The impairment provision for the three months ended September 30, 2013 was $4,000, compared to $297,000 for the corresponding period in 2012.

Accretion and Amortization of Future Restoration Costs

During the first nine months of 2013 and 2012, the accretion and amortization of future restoration costs were $292,000 and $69,000, respectively. This increase of $223,000 was primarily due to a modification in the interest rate used in the calculation.

During the three months ended September 30, 2013, the accretion and amortization of future restoration costs was $97,000, compared to $23,000 for the corresponding period in 2012. This increase of $74,000 was primarily due to a modification in the interest rate used in the calculation.

General and Administrative Charges

We incurred general and administrative charges, including corporate depreciation, of $6.8 million and $8.2 million in the first nine months of 2013 and 2012, respectively.

During the three months ended September 30, 2013, general and administrative charges, excluding corporate depreciation totaled $2.2 million, compared to $3.0 million for the corresponding period in 2012. Included in these costs were approximately $190,000 of one-time items resulting from the relocation of the Company’s corporate office from Lewisville, TX to Centennial, CO.  Excluding these one-time costs further highlights the underlying trend of decreasing general and administrative expenses.

Significant expenditures for general and administrative expenses for the three and nine months ended September 30, 2013 and 2012 were:

15

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2013		2012		2013		2012
Stock compensation expense	$	116,000	$	62,000	$	299,000	$	374,000
Salaries and payroll burden	726,000		815,000		2,324,000		2,705,000
Legal, accounting, and public company expenses	614,000		841,000		1,916,000		2,900,000
Insurance and bank fees	278,000		243,000		738,000		548,000
Consulting and professional services	101,000		816,000		554,000		1,051,000
Office, travel and other expenses	340,000		218,000		919,000		613,000
Total	$	2,175,000	$	2,995,000	$	6,750,000	$	8,191,000

During the first nine months of 2013 and 2012, non-cash stock compensation expense was $299,000 and $374,000, respectively. This decrease of $75,000 resulted primarily from the adjustment for stock option forfeitures. During the three months ended September 30, 2013, non-cash stock compensation expense was $116,000, as compared to non-cash stock compensation expense of $62,000 for the corresponding period in 2012.

Salaries and payroll burden decreased $381,000 in the first nine months of 2013, as compared to the same period in 2012, due to a reduction in headcount and the consolidation of operations.  During the three months ended September 30, 2013, salaries and payroll burden totaled $726,000, compared to $815,000 for the corresponding period in 2012.

The Company’s legal, accounting and public company expenses decreased $984,000 in the first nine months of 2013, compared to the same period in 2012, during which time the Company incurred additional costs associated with the merger of Neutron Energy, Inc. and Kleberg County litigation defense costs. During the three months ended September 30, 2013, legal, accounting and public company expenses totaled $614,000, compared to $841,000 for the corresponding period in 2012.

Insurance and bank fees increased $190,000 in the first nine months of 2013 as compared to the same period in 2012. The increase was due to an increase in general liability and umbrella insurance premiums resulting from the addition of the Neutron properties and payroll. Fees for bond premiums also increased in 2013, with the initiation of the bond program with Lexon Insurance in the first quarter of 2013, and the addition of Neutron properties. During the three months ended September 30, 2013, insurance and bank fees totaled $278,000, compared to $243,000 for the corresponding period in 2012.

Consulting and professional service expenses decreased by $497,000 for the nine months ended September 30, 2013, as compared to the same period in 2012. This decrease was the result of work performed in connection with the Company’s New Mexico UIC permit renewal, Churchrock Section 8 access and Churchrock Section 17 characterization activities in 2012. During the three months ended September 30, 2013, consulting and professional service expenses totaled $101,000, compared to $816,000 for the corresponding period in 2012. This decrease of $715,000 was the result of work performed during 2012 associated with the Company’s New Mexico UIC permit renewal, Churchrock Section 8 access and Churchrock Section 17 characterization activities.

The increase of $306,000 in office, travel and other expenses from $613,000 in the first nine months of 2012 to $919,000 in the 2013 period was due to added office rent, office consolidation expenses, and IT services costs. During the three months ended September 30, 2013, office, travel and other expenses totaled $340,000, compared to $218,000 for the corresponding period in 2012.

Net Losses

For the nine months ended September 30, 2013 and 2012, we had net losses of $11.9 million and $14.6 million, respectively.

For the three months ended September 30, 2013 and 2012, we had net losses of $3.2 million and $5.2 million, respectively.

Cash Flow

At September 30, 2013, we had a cash balance of approximately $2.0 million, compared with $4.0 million at the same date in 2012.

In the first nine months of 2013, cash used in operations was $11.5 million. Cash provided by investing activities was $5.4 million, the result of $5.5 million of restricted cash returned to the Company, less $0.1 million in property additions. During the period, cash generated from financing activities was $3.5 million, resulting from $3.6 million in cash raised through the sale of the Company’s common stock in connection with the Rights Offering that was completed in March 2013, less $0.1 million in cash used for lease payments.

16

In the first nine months of 2012, cash used in operations was $13.5 million. In the first nine months of 2012, we used $4.6 million in cash for investing activities which was primarily from the funding of Neutron administrative and development activities in connection with the merger agreement provisions of $3.7 million and additions made to our South Texas and New Mexico property, plant and equipment of $1.1 million during the period. These expenditures were primarily for land and mineral lease payments and plant construction at our properties in Texas during the period.

Liquidity—Cash Sources and Uses for 2013

As of September 30, 2013, the Company had $2.0 million in cash. The Company is not currently conducting uranium production activities. The Company is not projecting significant sales revenue and related cash inflows for 2013. During 2013, the Company is expected to complete the process of refurbishing its Kingsville Dome holding ponds and expects to generate a certain amount of uranium bearing product as a by-product of this pond project activity. The Company is currently assessing the pond project uranium bearing product to determine the quantity and quality of yellowcake that may be available for sale this year.

In March 2013, the Company completed a Shareholder Rights Offering (“Rights Offering”) in the amount of $8.6 million, whereby the Company received $3.6 million in cash, net of expenses and $5.0 million was used to repay the short term financing from its largest shareholder, Resource Capital Fund V L.P. (“RCF”). RCF owns approximately 32.8% of the Company’s common stock.

In February 2013, the Company secured $9 million in new surety bonds for the benefit of the Texas Commission on Environmental Quality for remediation and reclamation activities at the Company’s South Texas projects. The collateral requirements for these new bonds require the Company to post 40% of the face amount of the bonds ($3.6 million) in cash collateral as a condition of their terms. These bonds replaced the existing $9.0 million of fully collateralized financial surety instruments that previously provided the financial surety requirements for the projects. As a result of the lower cash collateral requirement, $5.4 million of the Company’s restricted cash was released back to the Company in April 2013.

On October 28, 2011, the Company entered into an At-The-Market Sales Agreement with BTIG, LLC, allowing the Company to sell from time to time common shares having an aggregate offering price of up to $15.0 million, through an “at-the-market” equity offering program (“ATM Sales Agreement”). The Company did not utilize the ATM Sales Agreement in the first nine months of 2013. The Company has a total of $9.0 million available for future sales under the ATM Sales Agreement.

After careful consideration of a variety of funding options, on October 14, 2013, the Company and its largest stockholder, Resource Capital Fund V L.P. (“RCF”) entered into a non-binding letter agreement (the “Letter Agreement”) whereby RCF agreed, subject to certain terms and conditions, to provide a secured convertible loan facility of up to $15.0 million to the Company (the “Facility”). RCF’s investment committee approved this Facility on October 17, 2013, subject to certain terms and conditions.

RCF’s commitment and investment committee approval to enter into the Facility is subject to numerous terms and conditions, including, among others, preparation and execution of definitive documentation, completion of due diligence satisfactory to RCF and stockholder approval of the Facility. Notwithstanding the absence of stockholder approval, a $3.0 million advance would be available to the Company following the closing of the Facility, which is expected to occur on or before November 15, 2013. Another $2 million would be available upon stockholder approval, which is expected to occur on or before January 31, 2014. Two additional tranches of $5.0 million each would be available in 2014 at the election of the Company. The Facility would be guaranteed by the Company’s subsidiaries and secured by substantially all of the Company’s assets.

RCF would have the option to convert all or any drawn portion of the Facility into shares of the Company’s common stock at any time following stockholder approval of the Facility and prior to maturity. The Company would have the option to prepay amounts drawn under the Facility without penalty, subject to RCF’s right to re-advance amounts prepaid for the purpose of converting such amounts. The conversion price is expected to be $2.60 per share, which may be subject to downward adjustment if the Company’s stock price averages below $2.60 per share for a period before the mailing required to achieve stockholder approval or if the Company issues equity securities below the conversion price in the year following the closing of the Facility. If the Company were to draw the entire $15.0 million proposed under the Facility and RCF were to convert such amount into shares of common stock at $2.60 per share, RCF’s ownership in the Company would increase from approximately 32.8% to approximately 51.0%.

The Letter Agreement is non-binding. While management believes the Facility will be available to the Company on the terms outlined above, there can be no assurance that the Facility will be available on or before November 15, 2013 or that the Facility will be completed on the terms contemplated or on other terms. As of October 21, 2013, the Company had a cash balance of approximately $1.3 million. On average, the Company has been expending approximately $1.3 million of cash per month during the first nine months of 2013 and expects to spend $1.1 million per month during the balance of 2013. If adequate funds are not available through the Facility, the Company will need to seek alternative sources of debt or equity capital and to the extent that the Company raises additional capital through the sale of equity or convertible debt securities, the issuance of such securities would likely result in substantial dilution to existing stockholders. There can be no assurance that the Company will be able to obtain additional capital if the

17

Facility does not close, that the terms of alternative capital would not be less favorable to the Company or that such additional capital could be obtained on a timely basis, if at all. If additional capital is not available in sufficient amounts or on a timely basis, the Company will experience liquidity problems in the near future, and the Company could face the need to significantly curtail current operations, change our planned business strategies and pursue other remedial measures.

Going Concern

The Company’s condensed consolidated interim financial statements have been prepared assuming that the Company will continue as a going concern; however, should the Company be unsuccessful in closing the financing transaction with RCF discussed above, it would raise substantial doubt about the Company’s ability to do so. The condensed consolidated interim financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result should the Company be unable to continue as a going concern.

Off Balance Sheet Arrangements

In February 2013, the Company secured $9 million in new surety bonds from Lexon Insurance Company (“Lexon”) for the benefit of the Texas Commission on Environmental Quality for remediation and reclamation activities at the Company’s South Texas projects. The collateral requirements for these new bonds require the Company to post 40% of the face amount of the bonds ($3.6 million) in cash collateral as a condition of their terms. These bonds replaced the existing $9.0 million of fully cash collateralized financial surety instruments that previously provided the financial surety requirements for the projects. In the event that Lexon is required to perform under its bonds or the bonds are called by the state agencies, the Company would be obligated to pay costs incurred by Lexon that exceeded the collateral amounts.

Critical Accounting Policies

Our significant accounting policies are described in Note 3 to the consolidated financial statements included in the Company’s 2012 Annual Report on Form 10-K/A. We believe our most critical accounting policies involve those requiring the use of significant estimates and assumptions in determining values or projecting future costs.  Such estimates and assumptions affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period.

Specifically regarding our uranium properties, significant estimates were utilized in determining the carrying value of these assets. These assets have been recorded at their estimated net realizable value for impairment purposes, which is less than our cost. The actual value realized from these assets may vary significantly from these estimates based upon market conditions, financing availability and other factors.  Future market conditions in particular can be difficult to predict and measure because of the impact of events that affect public acceptance of nuclear energy, the limited size of the market for the use of uranium, changes in the prices of alternative energy sources, development of new low-cost alternative energy sources and other factors.

Regarding our reserve for future restoration and reclamation costs, significant estimates were utilized in determining the future costs to complete the groundwater restoration and surface reclamation at our mine sites. Estimating future costs can be difficult and unpredictable because they are based principally on current legal and regulatory requirements and mine closure plans that may change materially.  The laws and regulations governing mine closure and remediation in a particular jurisdiction are subject to review at any time and may be amended to impose additional requirements and conditions which may cause our provisions for environmental liabilities to be underestimated and could materially affect our financial position or results of operations. Estimates of future restoration and reclamation costs are also subject to operational risks such as acceptance of treatment techniques or other operational changes.

Also, the calculation of reserves, other mineralized material and grading are estimates and depend upon geological interpretation and statistical inferences or assumptions drawn from drilling and sampling analysis, which may prove to be unpredictable. There is a degree of uncertainty attributable to the calculation of reserves, mineralized material and corresponding grades. Until reserves and other mineralized materials are actually mined and processed, the quantity of ore and grades must be considered as an estimate only. In addition, the quantity of reserves and other mineralized materials and ore may vary depending on the price of uranium. Any material change in the quantity of reserves, other mineralized materials, mineralization or grade may affect the economic viability of our properties.

The accounts of the Company are maintained in United States dollars. All dollar amounts in the financial statements are stated in United States dollars except where indicated.

18

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

There has been no material change to the information reported under Part II, Item 7A, “Quantitative and Qualitative Disclosures About Market Risk” contained in our Annual Report on Form 10-K/A for the year ended December 31, 2012.

ITEM 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures (Restated)

The Company maintains disclosure controls and procedures that are designed to ensure that information required to be disclosed in its filings with the Securities and Exchange Commission (“SEC”) is recorded, processed, summarized and reported within the time period specified in the SEC’s rules and forms, and that such information is accumulated and communicated to management, including the Company’s Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, management has recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management is required to apply judgment in evaluating the Company’s controls and procedures.

Prior to the filing of the Original Form 10-Q for the fiscal period covered by this report, the Company’s management, with the participation of the CEO and CFO of the Company, carried out an evaluation of the effectiveness of the design and operation of the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended).

Based on that evaluation, the CEO and CFO concluded that the Company’s disclosure controls and procedures were effective as of September 30, 2013. As described in Part II, Item 9A, “Management’s Report on Internal Control Over Financial Reporting (Restated)” included in the Form 10-K/A filed on December 17, 2013, the Company subsequently determined that there was a material weakness in its internal control over financial reporting as of December 31, 2012 due to the restatement described below and in Note 3 to the condensed consolidated financial statements included elsewhere in this quarterly report, and that such material weakness also existed as of September 30, 2013. As a result, the Company’s management, with the participation of the CEO and CFO, reevaluated the effectiveness of the Company’s disclosure controls and procedures as of September 30, 2013, and the CEO and CFO of the Company concluded that, because of the material weakness in the Company’s internal control over financial reporting, the Company’s disclosure controls and procedures were not effective as of September 30, 2013.

A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the annual or interim financial statements will not be prevented or detected on a timely basis.

As disclosed in our Annual Report on Form 10-K/A for the year ended December 31, 2012, we previously identified a material weakness in our internal control over financial reporting of certain costs capitalized as development costs at our New Mexico and Texas properties regarding the treatment of such costs under United States generally accepted accounting principles (“U.S. GAAP”) and Industry Guide 7, which do not allow for capitalization of costs on mineral properties which do not have proven or probable reserves declared.  As a result, management has restated the Management’s Report on Internal Control Over Financial Reporting as of December 31, 2012 included in the Form 10-K/A.  The Company’s management believes that this incident is related to the interpretation of Industry Guide 7 and specific accounting literature under U.S. GAAP and is isolated. Management has taken steps to ensure that the Company’s accounting staff is knowledgeable about Industry Guide 7 and its application to the Company. Other than such steps, the Company’s management believes that no additional corrective action is necessary to remedy the material weakness, and the Company believes that the Company’s current accounting management has an appropriate level of accounting knowledge, experience and training commensurate with the Company’s financial reporting requirements.

Changes in Internal Controls

During the three months ended September 30, 2013 no material changes have been made in our internal control over financial reporting that may have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

19

PART II - OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

Litigation

On August 2, 2013, Thomas H. Ehrlich, the Company’s former chief financial officer, filed a complaint against the Company in the District Court of Denton County, Texas, Cause No. 2013-61011-393. The complaint alleges that the Company breached a compensation agreement between the Company and Mr. Ehrlich that provided for certain payments to Mr. Ehrlich upon certain change in control events. On August 13, 2013, the Company filed a general denial of the allegations contained in the complaint. The Company intends to vigorously defend any assertions related to the above lawsuit. The Company estimates the lawsuit could take approximately one year to be resolved and does not believe that the outcome of the lawsuit will have a material adverse impact on the Company’s financial position, results of operations or liquidity.

ITEM 1A. RISK FACTORS

Other than as set forth below, there have been no material changes from those risk factors set forth in our Annual Report on Form 10-K/A for the year ended December 31, 2012.

We have received Comment Letters from the Staff of the SEC which may require us to restate our historical financial statements.

In connection with a routine review of our Exchange Act reports by the staff of the SEC’s Division of Corporation Finance (the “Staff”) we have received letters from the Staff setting forth comments and questions with respect to our Annual Report on Form 10-K for the year ended December 31, 2012 (the “Comment Letters”) and the Company has submitted responses to such letters. Among other things, the Comment Letters have questioned the capitalization of certain costs (primarily in connection with land holding, physical plant and permits) relating to projects without reserves, defined as proven and probable in accordance with the SEC’s Industry Guide 7, and the Company’s practices with regard to testing assets for impairment.  The Staff has also questioned the Company’s disclosure of pounds of U3O8 for non-mineralized resources when Industry Guide 7 permits the disclosure of mineralized materials only in terms of tons and grade. We have been corresponding with the Staff regarding these matters and a resolution has not been reached at this time.

We believe that our capitalization and impairment testing practices have been undertaken in accordance with generally accepted accounting principles and related current accounting literature, but there can be no assurances that the Staff will concur with our assessment. If it is ultimately determined that the Company improperly capitalized costs, the Company would likely need to restate its historical financial statements to expense certain costs that were previously capitalized. As of the date of this Quarterly Report on Form 10-Q, we estimate that, if we are precluded from capitalizing any of these amounts, the impact of expensing such costs would be to reduce property, plant and equipment on our consolidated balance sheets by up to approximately $9.0 million (consisting of approximately $7.7 million related to costs associated with our New Mexico projects and approximately $1.3 million related to our ISR well fields in South Texas), with corresponding increases in operating expense and exploration and land maintenance expense on our consolidated statements of operations, as well as increases to our losses by these amounts, and conforming changes to our consolidated statements of shareholders’ equity and consolidated statements of cash flows in the relevant periods. Following such restatement, property, plant and equipment as reflected on our consolidated balance sheets could decrease from approximately $108.9 million to approximately $99.9 million. If it is ultimately determined that the Company improperly failed to conduct impairment testing on its assets due to declines in the price of uranium or otherwise, the Company would need to undertake such testing and could be forced to write-down the value of certain assets, which could also require the Company to restate its historical financial statements. Between the potential re-characterization of costs and any write-downs following impairment testing, a substantial majority, if not all, of property, plant and equipment (which constitutes most of our assets) could be removed from our consolidated balance sheets.

Our consolidated financial statements contained in this Quarterly Report on Form 10-Q/A were prepared in accordance with our existing accounting policies, using assumptions which we believe are appropriate based on current facts and circumstances, all of which are consistent with those applied in prior audited periods. See “Critical Accounting Policies” in “Item 2 — Management’s Discussion and Analysis of Financial Condition and Results of Operations” for a discussion of our accounting policies and assumptions related to our accounting policies.

While we intend to continue our discussion with the Staff to resolve the Comment Letters, there is no guarantee that we will be successful. Because the issues questioned by the Staff are non-cash related issues, we do not anticipate that an adverse determination would affect the Company’s operations or ability to continue as a going concern. In the event that the Company is required to restate its consolidated financial statements in prior periods, such restatement would likely have a material adverse effect on our consolidated balance sheets and consolidated statements of operations. We would be required to announce that our historical financial statements could not be relied on and to file restated financial statements with the SEC, which could be costly and take considerable time to

20

prepare. Until any required restated financial statements had been filed our ability to raise money in the public markets could be adversely affected and our public stock price could decline.

We may not have sufficient cash to fund our operations through December 31, 2013, and if we are unable to raise additional capital, our business may fail and stockholders may lose their entire investment.

We had approximately $2.0 million in cash at September 30, 2013 and approximately $1.3 million as of October 21, 2013. On average, the Company has been expending approximately $1.3 million of cash during the first nine months of 2013 and expects to spend $1.1 million per month during the balance of 2013. We currently do not have sufficient cash to fund our operations through December 31, 2013 and we will need to raise additional capital to fund our operations through December 31, 2013 and beyond.

On October 14, 2013, the Company and its largest stockholder, RCF, entered into a non-binding letter agreement (the “Letter Agreement”) whereby RCF agreed, subject to the terms and conditions set forth in the Letter Agreement, to provide a secured convertible loan facility of up to $15.0 million to the Company (the “Facility”). Management currently anticipates that the Facility will close on or before November 15, 2013. See Part I, Item 2 Management’s Discussion and Analysis of Financial Condition and Results of Operations—“Liquidity—Cash Sources and Uses for 2013” for additional information about the Letter Agreement and Facility.

There can be no assurance that the Facility will be available on or before November 15, 2013 or that the Facility will be completed on the terms contemplated or on other terms. If adequate funds are not available through the Facility, the Company will need to seek alternative sources of debt or equity capital, and to the extent that the Company raises additional capital through the sale of equity or convertible debt securities, the issuance of such securities would likely result in substantial dilution to existing stockholders. If the Company borrows money, we will have to pay interest and may also have to agree to restrictions that limit our operating flexibility.

There can be no assurance that the Company will be able to obtain additional capital if the Facility does not close, that the terms of alternative capital would not be less favorable to the Company or that such additional capital could be obtained on a timely basis, if at all. If additional capital is not available in sufficient amounts or on a timely basis, the Company will experience liquidity problems in the near future, and the Company could face the need to significantly curtail current operations, change our planned business strategies and pursue other remedial measures.  Any curtailment of business operations would have a material negative effect on operating results, the value of our outstanding stock is likely to fall, and our business may fail, causing our stockholder to lose their entire investment.

Approximately 32.8% of our common stock is controlled by a significant stockholder that may acquire additional shares.

As of October 28, 2013, approximately 32.8% of our common stock is beneficially owned by RCF. In addition, under the terms of the proposed Facility, RCF would have the right to acquire additional shares of our common stock upon conversion of amounts drawn on the Facility (including amounts previously repaid) and in satisfaction of interest and fees thereunder. See Part I, Item 2 Management’s Discussion and Analysis of Financial Condition and Results of Operations—“Liquidity—Cash Sources and Uses for 2013.” If the Company were to draw $15.0 million under the Facility and RCF were to convert such amount into shares of our common stock, RCF’s ownership in the Company would increase to approximately 51.0%. RCF could also receive a significant number of additional shares if we were to sell equity or equity-linked securities in the year following the closing of the Facility at a price below RCF’s conversion price. In addition, under a stockholders’ agreement between RCF and the Company, RCF is entitled to have two designees placed in nomination for a seat on the Company’s Board of Directors, and RCF has the right to participate in future equity offerings by the Company in proportion to its percentage ownership of the outstanding shares of our common stock.

Because of RCF’s ownership of URI common stock, RCF has the ability to exercise a substantial degree of control over matters requiring stockholder approval. Those matters include the election of directors, amendments to the certificate of incorporation and approval of significant corporate transactions. This control could have the effect of delaying or preventing a change of control of the Company or changes in management and will make the approval of certain transactions difficult without the support of RCF, including transactions in which other stockholders might otherwise receive a premium for their shares over the then-current market price. In addition, RCF could privately sell control of the Company without other stockholders realizing any change-of-control premium. RCF may also have other interests that are different from, in addition to or not always consistent with the Company’s interests or with the interests of other stockholders.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

During the quarter ended September 30, 2013, no unregistered securities were sold.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None.

21

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5. OTHER INFORMATION

None.

ITEM 6. EXHIBITS

See the Index to Exhibits on Page E-1 for a listing of the exhibits that are filed as part of this Quarterly Report.

22

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	URANIUM RESOURCES, INC.
Dated: December 17, 2013	By:	/s/ Christopher Jones
		Christopher Jones
		President and Chief Executive Officer
Dated: December 17, 2013	By:	/s/ Jeffrey L. Vigil
		Jeffrey L. Vigil
		Vice President - Finance and Chief Financial Officer
		(Principal Financial and Accounting Officer)

23

EXHIBIT INDEX

Exhibit Number	Description
3.1	Amended and Restated Bylaws of the Company, effective July 30, 2013 (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed on August 2, 2013).
10.1	Uranium Supply Contract, effective July 11, 2013, between URI, Inc. and ITOCHU International Inc. (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on July 18, 2013).
31.1	Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2	Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1	Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2	Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101	The following financial information from the quarterly report on Form 10-Q/A of Uranium Resources, Inc. for the quarter ended September 30, 2013, formatted in XBRL (extensible Business Reporting Language): (i) Condensed Consolidated Statements of Operations, (ii) Condensed Consolidated Balance Sheets, (iii) Condensed Consolidated Statements of Cash Flows and (v) Notes to the Condensed Consolidated Financial Statements.

E-1

EX-31.1

Exhibit 31.1

Certification of Chief Executive Officer

Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Christopher Jones, certify that:

1. I have reviewed this report on Form 10-Q/A of Uranium Resources, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: December 17, 2013

/s/ Christopher Jones

Title: President and Chief Executive Officer

EX-31.2

Exhibit 31.2

Certification of Chief Financial Officer

Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Jeffrey L. Vigil, certify that:

1. I have reviewed this report on Form 10-Q/A of Uranium Resources, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report.

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: December 17, 2013

/s/ Jeffrey L. Vigil

Title: Vice President - Finance and Chief Financial Officer

EX-32.1

Exhibit 32.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Christopher Jones, President and Chief Executive Officer of Uranium Resources, Inc. (the “Company”), certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

(1) The Quarterly Report on Form 10-Q/A of the Company for the period ended September 30, 2013 which this certification accompanies fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ Christopher Jones

Christopher Jones

President and Chief Executive Officer

December 17, 2013

EX-32.2

Exhibit 32.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Jeffrey L. Vigil, Vice President - Finance and Chief Financial Officer of Uranium Resources, Inc. (the “Company”), certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

(1) The Quarterly Report on Form 10-Q/A of the Company for the period ended September 30, 2013, which this certification accompanies fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ Jeffrey L. Vigil

Jeffrey L. Vigil

Vice President - Finance and Chief Financial Officer

December 17, 2013

XML

PROPERTY, PLANT AND EQUIPMENT (Tables)

9 Months Ended

Sep. 30, 2013

PROPERTY, PLANT AND EQUIPMENT

Schedule of property, plant and equipment

	Property, Plant and
	Equipment, net at:
	9/30/2013		12/31/2012
	(Restated)		(Restated)
Uranium plant	$	9,451,000	$	9,532,000
Permits and licenses	174,000		174,000
Mineral rights and properties	20,874,000		20,872,000
Evaluation and delineation	2,022,000		2,022,000
Vehicles/depreciable equipment	1,230,000		1,435,000
Other property, plant and equipment	596,000		705,000
Total	$	34,347,000	$	34,740,000

XML

Condensed Consolidated Statements of Operations (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Cost of uranium sales:
Operating expenses	$ 568,033	$ 776,764	$ 1,886,157	$ 1,920,601
Mineral property expenses	371,984	981,657	1,796,313	3,215,697
Accretion/amortization of asset retirement obligations	97,435	22,673	292,305	69,416
Depreciation and depletion	76,089	91,319	225,907	318,637
Impairment of uranium properties	3,701	296,628	683,356	1,048,400
Total cost of uranium sales	1,117,242	2,169,041	4,884,038	6,572,751
Loss from operations before corporate expenses	(1,117,242)	(2,169,041)	(4,884,038)	(6,572,751)
Corporate expenses:
General and administrative	2,174,862	2,994,663	6,749,980	8,191,352
Depreciation	32,631	40,911	115,773	104,751
Total corporate expenses	2,207,493	3,035,574	6,865,753	8,296,103
Loss from operations	(3,324,735)	(5,204,615)	(11,749,791)	(14,868,854)
Other income and expense:
Interest expense	(3,859)	(6,055)	(253,485)	(12,723)
Interest and other income, net	55,703	20,501	60,238	247,678
Net loss	$ (3,272,891)	$ (5,190,169)	$ (11,943,038)	$ (14,633,899)
Basic and diluted net loss per common share (in dollars per share)	$ (0.16)	$ (0.42)	$ (0.63)	$ (1.34)
Average weighted shares outstanding (in shares)	19,820,258	12,413,476	18,995,957	10,953,407

XML

PROPERTY, PLANT AND EQUIPMENT

9 Months Ended

Sep. 30, 2013

PROPERTY, PLANT AND EQUIPMENT

PROPERTY, PLANT AND EQUIPMENT

5. PROPERTY, PLANT AND EQUIPMENT

Certain of the balances presented below have been restated as described in Note 3:

	Property, Plant and
	Equipment, net at:
	9/30/2013		12/31/2012
	(Restated)		(Restated)
Uranium plant	$	9,451,000	$	9,532,000
Permits and licenses	174,000		174,000
Mineral rights and properties	20,874,000		20,872,000
Evaluation and delineation	2,022,000		2,022,000
Vehicles/depreciable equipment	1,230,000		1,435,000
Other property, plant and equipment	596,000		705,000
Total	$	34,347,000	$	34,740,000

Impairment of Uranium Properties

The Company shut-in production at certain of its South Texas properties in 2009.  The Company reviews the estimated cost of restoration and remediation activities on these particular mineral properties at each quarter end.  For any increase in estimated cost, the Company initially records the change on its balance sheet by increasing the mineral property asset and increasing the asset retirement obligation in accordance with U.S. generally accepted accounting principles (ASC 410-20-35-8).  However, because there is no further production expected from these particular South Texas properties, the increase in costs recorded to the mineral property asset are then expensed as impairment expense on the statement of operations.

For the nine months ended September 30, 2013 and 2012, as a result of the accounting procedure described above, and the write-offs described above, the Company recorded impairment costs in the amount of approximately $683,000 and $1,048,000, respectively.  The impairment provision for the three months ended September 30, 2013 was $4,000, compared to $297,000 for the corresponding period in 2012.

XML

PROPERTY, PLANT AND EQUIPMENT (Details) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012	Dec. 31, 2012
PROPERTY, PLANT AND EQUIPMENT
Property, Plant and Equipment Balances (net)	$ 34,347,105		$ 34,347,105		$ 34,739,746
Impairment provision	3,701	296,628	683,356	1,048,400
Uranium plant
PROPERTY, PLANT AND EQUIPMENT
Property, Plant and Equipment Balances (net)	9,451,000		9,451,000		9,532,000
Permits and licenses
PROPERTY, PLANT AND EQUIPMENT
Property, Plant and Equipment Balances (net)	174,000		174,000		174,000
Mineral rights and properties
PROPERTY, PLANT AND EQUIPMENT
Property, Plant and Equipment Balances (net)	20,874,000		20,874,000		20,872,000
Evaluation and delineation
PROPERTY, PLANT AND EQUIPMENT
Property, Plant and Equipment Balances (net)	2,022,000		2,022,000		2,022,000
Vehicles/depreciable equipment
PROPERTY, PLANT AND EQUIPMENT
Property, Plant and Equipment Balances (net)	1,230,000		1,230,000		1,435,000
Other property, plant and equipment
PROPERTY, PLANT AND EQUIPMENT
Property, Plant and Equipment Balances (net)	$ 596,000		$ 596,000		$ 705,000

XML

SHAREHOLDERS' EQUITY (Tables)

9 Months Ended

Sep. 30, 2013

SHAREHOLDERS' EQUITY

Schedule of changes in shareholders' equity

	Common Stock			Paid-In			Accumulated			Treasury
	Shares	Amount		Capital			Deficit			Stock
							(Restated)
Balances, December 31, 2012, as reported	16,150,163	$	16,154	$	207,338,549		$	(162,201,908	)	$	(9,418	)
Prior period adjustment	—	—		—			(8,974,335		)	—
Balances, December 31, 2012, as restated	16,150,163	$	16,154	$	207,338,549		$	(171,176,243	)	$	(9,418	)
Net loss, restated	—	—		—			(11,943,038		)
Stock compensation expense	—	—		299,286			—			—
Common stock issued - payment of loan principal and interest services	1,992,127	1,992		5,093,841			—			—
Common stock issued - shareholder rights offering	1,547,843	1,548		3,597,884			—			—
Common stock issued for services	83,200	83		291,417			—			—
Restricted stock issuance	46,925	47		(47		)	—			—
Balances, September 30, 2013, as restated	19,820,258	$	19,824	$	216,620,930		$	(183,119,281	)	$	(9,418	)

XML

STOCK BASED COMPENSATION (Details 2) (USD $)	9 Months Ended
	Sep. 30, 2013
Outstanding Options, Number of Shares
Outstanding at the beginning of the period (in shares)	317,270
Granted (in shares)	60,000
Canceled or forfeited (in shares)	(72,791)
Outstanding at the end of the period (in shares)	304,479
Exercisable at the end of the period (in shares)	226,980
Outstanding Options, Weighted Average Exercise Price
Outstanding at the beginning of the period (in dollars per share)	$ 24.62
Granted (in dollars per share)	$ 2.85
Canceled or forfeited (in dollars per share)	$ 25.90
Outstanding at the end of the period (in dollars per share)	$ 20.02
Exercisable at the end of the period (in dollars per share)	$ 25.57
Outstanding Options, Weighted Average Remaining Contractual Term
Outstanding at the end of the period	4 years 1 month 6 days
Exercisable at the end of the period	2 years 3 months 18 days

XML

STOCK BASED COMPENSATION (Details) (USD $)	9 Months Ended			9 Months Ended			0 Months Ended	6 Months Ended	0 Months Ended	9 Months Ended		0 Months Ended		6 Months Ended	0 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013 2013 Omnibus Incentive Plan	Sep. 30, 2013 Minimum	Sep. 30, 2013 Maximum	Sep. 30, 2013 Stock options	Mar. 12, 2013 Stock options President/CEO	Jun. 30, 2013 Stock options Former Executive Officer	Jan. 16, 2013 Stock options Non-employee Directors	Sep. 30, 2013 Stock options Minimum	Sep. 30, 2013 Stock options Maximum	Mar. 12, 2013 Restricted stock President/CEO	Mar. 12, 2013 Restricted stock Former Executive Officer	Jun. 30, 2013 Restricted stock Former Executive Officer	Jun. 04, 2013 Restricted stock units President/CEO 2013 Omnibus Incentive Plan	Jun. 04, 2013 Restricted stock units Non-employee Directors 2013 Omnibus Incentive Plan	Jul. 30, 2013 Restricted stock units Vice President-Finance and Chief Financial Officer 2013 Omnibus Incentive Plan
Stock-Based Compensation Plans
Stock compensation expense (in dollars)	$ 299,000	$ 374,000						$ 134,000						$ 43,000
Stock options granted (in shares)	60,000						55,000		5,000
Restricted stock granted (in shares)												25,000	25,000		100,000	100,000	80,000
Fair market value (in dollars per share)							$ 1.98		$ 3.30
Fair value of award issued (in dollars per share)												$ 2.73			$ 2.83	$ 2.83	$ 4.50
Total estimated unrecognized compensation cost (in dollars)	$ 1,058,000
Vesting period				1 year	3 years		3 years					3 years			3 years	3 years	3 years
Shares available for grant			1,000,000			907,914
Assumptions used to estimate fair value of stock options granted to employees and directors
Risk free rate (as a percent)										1.40%	2.16%
Expected life										5 years 8 months 12 days	7 years 9 months 18 days
Expected volatility (as a percent)										84.00%	89.00%
Expected dividend yield (as a percent)	0.00%

XML

COMMITMENTS AND CONTINGENCIES (Details) (Supply contract, Itochu)	1 Months Ended
	Jul. 31, 2013 lb
Supply contract | Itochu
Supply Commitment
Percentage of production from the Company's Vasquez, Rosita or Kingsville properties purchased by party	50.00%
Maximum commitment to supply number of units of U3O8 (in pounds)	3,000,000
Discount percentage when the market price is $56.50 per pound of U3O8 or less	5.00%
Market price (in dollars per pound)	56.50
Discount percentage when the market price is greater than $56.50 per pound	7.00%

XML

SHAREHOLDERS' EQUITY (Details) (USD $)	0 Months Ended	3 Months Ended		9 Months Ended		3 Months Ended		9 Months Ended		3 Months Ended		9 Months Ended		1 Months Ended	3 Months Ended		7 Months Ended	1 Months Ended	9 Months Ended		9 Months Ended		9 Months Ended
	Jan. 22, 2013	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013 As Reported	Sep. 30, 2012 As Reported	Sep. 30, 2013 As Reported	Sep. 30, 2012 As Reported	Sep. 30, 2013 Adjustment	Sep. 30, 2012 Adjustment	Sep. 30, 2013 Adjustment	Sep. 30, 2012 Adjustment	Mar. 31, 2013 Rights offering item	Mar. 31, 2013 RCF Short term financing	Dec. 31, 2012 RCF Short term financing	Sep. 30, 2013 RCF Short term financing	Mar. 31, 2013 RCF Rights offering Short term financing	Sep. 30, 2013 Common Stock	Dec. 31, 2012 Common Stock As Reported	Sep. 30, 2013 Paid-In Capital	Dec. 31, 2012 Paid-In Capital As Reported	Sep. 30, 2013 Accumulated Deficit	Dec. 31, 2012 Accumulated Deficit As Reported	Dec. 31, 2012 Accumulated Deficit Adjustment	Sep. 30, 2013 Treasury Stock	Dec. 31, 2012 Treasury Stock	Dec. 31, 2012 Treasury Stock As Reported
SHAREHOLDERS' EQUITY
Reverse stock split ratio	0.1
Common stock outstanding before reverse stock split (in shares)	161,100,000
Common stock, shares outstanding	16,100,000	19,820,258		19,820,258															19,820,258	16,150,163
Changes in shareholders equity
Balance at the beginning of the period (in shares)				16,150,163															16,150,163	16,150,163
Balance at the beginning of the period				$ 36,169,042															$ 16,154	$ 16,154	$ 207,338,549	$ 207,338,549	$ (171,176,243)	$ (162,201,908)	$ (8,974,335)	$ (9,418)	$ (9,418)	$ (9,418)
Net loss, restated		(3,272,891)	(5,190,169)	(11,943,038)	(14,633,899)	(3,949,264)	(4,220,914)	(11,946,442)	(11,488,063)	676,373	(969,255)	3,404	(3,145,836)										(11,943,038)
Stock compensation expense																					299,286
Common stock issued - payment of loan principal and interest services (in shares)																	31,343		1,992,127
Common stock issued - payment of loan principal and interest services																			1,992		5,093,841
Common stock issued - shareholder rights offering (in shares)																			1,547,843
Common stock issued - shareholder rights offering																			1,548		3,597,884
Common stock issued for services (in shares)																			83,200
Common stock issued for services				291,500															83		291,417
Restricted stock issuance (in shares)																			46,925
Restricted stock issuance				47	391														47		(47)
Balance at the end of the period (in shares)	16,100,000	19,820,258		19,820,258															19,820,258	16,150,163
Balance at the end of the period		33,512,055		33,512,055		42,482,986		42,482,986		(8,970,931)		(8,970,931)							19,824	16,154	216,620,930	207,338,549	(183,119,281)	(162,201,908)	(8,974,335)	(9,418)	(9,418)	(9,418)
Short term financing repaid																		5,000,000
Number of shares of common stock issued upon conversion																		1,960,000
Interest accrued on the loan															79,167	16,667
Number of subscription rights issued for each share of common stock owned or subject to a warrant														1
Number of non-transferrable subscription rights received (in shares)														0.3119
Exercise price (in dollars per share)														$ 2.55
Net proceeds from sale of shares of common stock in cash				$ 3,599,432	$ 19,328,360									$ 3,600,000

XML

DESCRIPTION OF BUSINESS

9 Months Ended

Sep. 30, 2013

DESCRIPTION OF BUSINESS

DESCRIPTION OF BUSINESS

1. DESCRIPTION OF BUSINESS

Uranium Resources, Inc. (URI) is a uranium exploration, development and production company. We were organized in 1977 to acquire and develop uranium mines in South Texas using the in-situ recovery mining process (ISR). URI has historically produced uranium by ISR methods in the State of Texas where the Company currently has ISR mining projects, including two licensed processing facilities. We also have mineral holdings in New Mexico and a NRC license to produce up to 3 million pounds per annum of uranium on certain of our New Mexico projects. The Company acquired these properties over the past 20 years along with an extensive information database of historic mining logs and analysis. None of URI’s properties are currently in production.

XML

RESTATEMENT

9 Months Ended

Sep. 30, 2013

RESTATEMENT

RESTATEMENT

3. RESTATEMENT

The Company determined that the capitalization of development costs primarily on its New Mexico mineral properties and to a lesser extent on its South Texas mineral properties was not in accordance with U.S. GAAP.  As a result, the Company has amended and restated its consolidated financial statements for the years ended December 31, 2012, 2011 and 2010, to reflect a cumulative adjustment to mineral property expenditures of $8,974,000 up to December 31, 2012.  These adjustments to property expenditures were previously capitalized as property, plant and equipment.

The Company has also restated the March 31, 2013 and June 30, 2013 interim condensed consolidated financial statements to expense certain costs previously capitalized as mineral property development costs. The Company has determined that its capitalization of these expenditures was not in accordance with U.S. GAAP.  As a result, the Company has amended and restated the interim condensed consolidated balance sheet as of September 30, 2013 to expense $762,000 of costs incurred during the nine-months ended September 30, 2013 that were previously capitalized as development costs to mineral property expenses, and reverse impairment costs recorded in the amount of $766,000.  The interim condensed consolidated statements of operations for the nine-month periods ended September 30, 2013 and 2012 were amended and restated to expense $762,000 and $3,146,000, respectively, of costs previously capitalized as development costs to mineral property expenses, and reverse impairment costs recorded during the nine-months ended September 30, 2013 in the amount of $766,000.  Corresponding changes were made to the interim statements of cash flows for the nine-months ended September 30, 2013 and 2012.

Consolidated Balance Sheet

	September 30, 2013
	As Reported		Adjustment		As Restated
	$		$		$
Assets
Property, plant and equipment	108,862,877		(8,970,931	)	99,891,946
Total Assets	49,802,689		(8,970,931	)	40,831,758
Shareholders’ equity
Accumulated deficit	(174,148,350	)	(8,970,931	)	(183,119,281	)
Total shareholders’ equity	42,482,986		(8,970,931	)	33,512,055
Total liabilities and shareholders’ equity	49,802,689		(8,970,931	)	40,831,758

Consolidated Statement of Operations

	Three Months Ended September 30, 2013
	As Reported		Adjustment		As Restated
	$		$		$
Mineral property expenses	282,478		89,506		371,984
Impairment of uranium properties	769,580		(765,879	)	3,701
Total cost of uranium sales	1,793,615		(676,373	)	1,117,242
Loss from operations before corporate expenses	(1,793,615	)	676,373		(1,117,242	)
Loss from operations	(4,001,108	)	676,373		(3,324,735	)
Net loss	(3,949,264	)	676,373		(3,272,891	)
Basic and diluted net loss per common share	(0.20	)	0.04		(0.16	)

Consolidated Statement of Operations

	Nine Months Ended September 30, 2013
	As Reported		Adjustment		As Restated
	$		$		$
Mineral property expenses	1,033,838		762,475		1,796,313
Impairment of uranium properties	1,449,235		(765,879	)	683,356
Total cost of uranium sales	4,887,442		(3,404	)	4,884,038
Loss from operations before corporate expenses	(4,887,442	)	3,404		(4,884,038	)
Loss from operations	(11,753,195	)	3,404		(11,749,791	)
Net loss	(11,946,442	)	3,404		(11,943,038	)
Basic and diluted net loss per common share	(0.63	)	0.00		(0.63	)

Consolidated Statement of Cash Flows

	Nine Months Ended September 30, 2013
	As Reported		Adjustment		As Restated
	$		$		$
Net loss	(11,946,442	)	3,404		(11,943,038	)
Impairment of uranium properties	1,449,235		(765,879	)	683,356
Additions to uranium properties	(884,640	)	762,475		(122,165	)

Consolidated Statement of Operations

	Three Months Ended September 30, 2012
	As Reported		Adjustment		As Restated
	$		$		$
Mineral property expenses	12,402		969,255		981,657
Total cost of uranium sales	1,199,786		969,255		2,169,041
Loss from operations before corporate expenses	(1,199,786	)	(969,255	)	(2,169,041	)
Loss from operations	(4,235,360	)	(969,255	)	(5,204,615	)
Net loss	(4,220,914	)	(969,255	)	(5,190,169	)
Basic and diluted net loss per common share	(0.34	)	(0.08	)	(0.42	)

Consolidated Statement of Operations

	Nine Months Ended September 30, 2012
	As Reported		Adjustment		As Restated
	$		$		$
Mineral property expenses	69,861		3,145,836		3,215,697
Total cost of uranium sales	3,426,915		3,145,836		6,572,751
Loss from operations before corporate expenses	(3,426,915	)	(3,145,836	)	(6,572,751	)
Loss from operations	(11,723,018	)	(3,145,836	)	(14,868,854	)
Net loss	(11,488,063	)	(3,145,836	)	(14,633,899	)
Basic and diluted net loss per common share	(1.05	)	(0.29	)	(1.34	)

Consolidated Statement of Cash Flows

	Nine Months Ended September 30, 2012
	As Reported		Adjustment		As Restated
	$		$		$
Net loss	(11,488,063	)	(3,145,836	)	(14,633,899	)
Additions to uranium properties	(4,278,130	)	3,145,836		(1,132,294	)

XML

SHAREHOLDERS' EQUITY

9 Months Ended

Sep. 30, 2013

SHAREHOLDERS' EQUITY

SHAREHOLDERS' EQUITY

6. SHAREHOLDERS’ EQUITY

Reverse Stock Split

Immediately following the close of trading on January 22, 2013, the Company completed a 1 for 10 reverse stock split for its common stock. With the reverse stock split, every ten shares of the Company’s issued and outstanding common stock were combined into one issued and outstanding share of common stock. The reverse stock split had no effect on the par value of the shares or the authorized number of shares of the Company. The reverse split reduced the number of URI’s outstanding common stock from approximately 161.1 million shares to approximately 16.1 million shares. All share data herein has been retroactively adjusted for the reverse stock split as of December 31, 2012.

The following table details the changes in shareholders’ equity for the nine months ended September 30, 2013:

	Common Stock			Paid-In			Accumulated			Treasury
	Shares	Amount		Capital			Deficit			Stock
							(Restated)
Balances, December 31, 2012, as reported	16,150,163	$	16,154	$	207,338,549		$	(162,201,908	)	$	(9,418	)
Prior period adjustment	—	—		—			(8,974,335		)	—
Balances, December 31, 2012, as restated	16,150,163	$	16,154	$	207,338,549		$	(171,176,243	)	$	(9,418	)
Net loss, restated	—	—		—			(11,943,038		)
Stock compensation expense	—	—		299,286			—			—
Common stock issued - payment of loan principal and interest services	1,992,127	1,992		5,093,841			—			—
Common stock issued - shareholder rights offering	1,547,843	1,548		3,597,884			—			—
Common stock issued for services	83,200	83		291,417			—			—
Restricted stock issuance	46,925	47		(47		)	—			—
Balances, September 30, 2013, as restated	19,820,258	$	19,824	$	216,620,930		$	(183,119,281	)	$	(9,418	)

See Note 7 - Stock Based Compensation for further discussion of stock compensation expense and restricted stock issuance.

Equity Infusion—Shareholder Rights Offering

In March 2013, the Company completed the Rights Offering, whereby each URI shareholder and warrant holder received one non-transferrable subscription right for each share of common stock owned or subject to a warrant as of 5:00pm ET on January 28, 2013. Every subscription right entitled the holder to purchase 0.3119 of a share of common stock of URI at a price of $2.55 per whole share.

Under the Rights Offering, the Company raised $3.6 million in cash, net of expenses and $5.0 million was used to repay the short term financing from RCF, whereby RCF was issued 1.96 million shares of the Company’s common stock. Also in connection with the RCF short term financing, the Company issued 31,343 shares of common stock in 2013 to pay fourth quarter 2012 and first quarter 2013 interest accrued on the loan of $16,667 and $79,167, respectively.

XML

LIQUIDITY AND GOING CONCERN

9 Months Ended

Sep. 30, 2013

LIQUIDITY AND GOING CONCERN

LIQUIDITY AND GOING CONCERN

4. LIQUIDITY AND GOING CONCERN

The Company had negative cash flow from operations of $11.5 million for the nine months ended September 30, 2013. Our cash position was $2.0 million at September 30, 2013. The Company is not currently commercially producing uranium and, as such, does not anticipate generating any significant sales revenues in 2013.

In March 2013, the Company completed a Shareholder Rights Offering (“Rights Offering”) in the amount of $8.6 million, whereby the Company received $3.6 million in cash, net of expenses and $5.0 million was used to repay the short term financing from its largest shareholder, Resource Capital Fund V L.P. (“RCF”). RCF owns approximately 32.8% of the Company’s common stock.

In February 2013, the Company secured a new source to satisfy its financial surety obligations for the Texas regulatory agencies. Previously, the Company had met its financial surety obligations through a combination of bank issued letters of credit (the “L/Cs”) and bonds issued for the benefit of the Company. These financial surety arrangements required the Company to fully collateralize the face amount of the L/C’s and the bonds with short term investment vehicles. This requirement resulted in the Company posting $9.3 million in cash that was restricted for the purpose of collateralizing these obligations. The Company’s new financial surety arrangements are provided by Lexon Insurance Company (“Lexon”) in the form of bonds issued for the benefit of the Company. The amount of the bonds written by Lexon total approximately $9.0 million and the collateral requirements of these bonds requires the Company to maintain 40% of the value of the bonds in the form of restricted cash. This change in collateral requirement occurred in April 2013 and reduced the amount of restricted cash required by the Company to $3.6 million and resulted in a corresponding increase in cash to the Company of $5.4 million.

In the fourth quarter of 2011, the Company entered into an At-The-Market Sales Agreement with BTIG, LLC, allowing the Company to sell from time to time its common shares having an aggregate offering price of up to $15.0 million, through an “at-the-market” equity offering program (“ATM Sales Agreement”). The Company did not make any sales under the ATM Sales Agreement in the third quarter of 2013 and has a total of $9.0 million available for future sales under the ATM Sales Agreement.

After careful consideration of a variety of financing options, on October 14, 2013, the Company and RCF entered into a non-binding letter agreement (the “Letter Agreement”) whereby RCF agreed, subject to the terms and conditions set forth in the Letter Agreement, to provide a secured convertible loan facility of up to $15.0 million to the Company (the “Facility”). RCF’s investment committee approved the Facility on October 17, 2013, subject to a number of conditions precedent and the terms and conditions in the Letter Agreement. The Facility would provide the Company with $3.0 million upon closing, which is expected on or before November 15, 2013, another $2 million would be available upon stockholder approval, which is expected to occur on or before January 31, 2014, and two additional tranches of $5.0 million each would be available in 2014 at the election of the Company.

There can be no assurance that the Facility will be available on or before November 15, 2013 or that the Facility will be completed on the terms contemplated or on other terms. As of October 21, 2013, the Company had a cash balance of approximately $1.3 million. On average, the Company has been expending approximately $1.3 million of cash per month during the first nine months of 2013 and expects to spend $1.1 million per month during the balance of 2013. If adequate funds are not available through the Facility, the Company will need to seek alternative sources of debt or equity capital and to the extent that the Company raises additional capital through the sale of equity or convertible debt securities, the issuance of such securities may result in substantial dilution to existing stockholders. There can be no assurance that the Company will be able to obtain additional capital if the Facility does not close, that the terms of alternative capital would not be less favorable to the Company or that such additional capital could be obtained on a timely basis, if at all. If additional capital is not available in sufficient amounts or on a timely basis, the Company will experience liquidity problems in the near future, and the Company could face the need to significantly curtail current operations, change planned business strategies and pursue other remedial measures.

The Company’s condensed consolidated interim financial statements have been prepared assuming that the Company will continue as a going concern; however, should the Company be unsuccessful in closing the financing transaction with RCF discussed above, it would raise substantial doubt about the Company’s ability to do so. The condensed consolidated interim financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result should the Company be unable to continue as a going concern.

XML

STOCK BASED COMPENSATION (Details 3) (USD $)	9 Months Ended
	Sep. 30, 2013	Dec. 31, 2012
Options Outstanding
Number of Options Outstanding (in shares)	304,479	317,270
Weighted Average Remaining Contractual Life	4 years 1 month 6 days
Weighted Average Exercise price (in dollars per share)	$ 20.02	$ 24.62
Options Exercisable
Number of Options Exercisable (in shares)	226,980
Weighted Average Exercise Price (in dollars per share)	$ 25.57
1995 Stock Incentive Plan
Options Outstanding
Number of Options Outstanding (in shares)	145,906
Weighted Average Remaining Contractual Life	10 months 24 days
Weighted Average Exercise price (in dollars per share)	$ 13.46
Options Exercisable
Number of Options Exercisable (in shares)	145,906
Weighted Average Exercise Price (in dollars per share)	$ 13.46
2004 Stock Incentive Plan
Options Outstanding
Number of Options Outstanding (in shares)	85,241
Weighted Average Remaining Contractual Life	7 years 9 months 18 days
Weighted Average Exercise price (in dollars per share)	$ 13.92
Options Exercisable
Number of Options Exercisable (in shares)	29,408
Weighted Average Exercise Price (in dollars per share)	$ 34.74
2004 Directors' Plan
Options Outstanding
Number of Options Outstanding (in shares)	73,332
Weighted Average Remaining Contractual Life	6 years 1 month 6 days
Weighted Average Exercise price (in dollars per share)	$ 40.19
Options Exercisable
Number of Options Exercisable (in shares)	51,666
Weighted Average Exercise Price (in dollars per share)	$ 54.57

XML

COMMITMENTS AND CONTINGENCIES (Details 2)	1 Months Ended	9 Months Ended	1 Months Ended
	Jun. 30, 2013 Vice President-Finance and Chief Financial Officer Y	Sep. 30, 2013 Other officers	Mar. 31, 2013 President and Chief Executive Officer Y
Employment Agreements
Period to receive certain rights and benefits in the event of change in control		24 months
Term of employment agreement	1 year		1 year
Automatic renewal term of the employment agreement	1 year		1 year
Number of year's base salary that will be paid in the event of termination of employment of the vice president following a change in control	1		2
Period within which salary and bonus will be entitled in the event of employment termination following a change in control	30 days		30 days
Period for salary and bonus entitlement in the event of company terminating the employment agreement other than for cause or elects not to renew the agreement	6 months		1 year
Period within which salary and bonus will be entitled in the event of company terminating the employment agreement other than for cause or elects not to renew the agreement	30 days		30 days

XML

Condensed Consolidated Balance Sheets (Parenthetical) (USD $)	Sep. 30, 2013	Dec. 31, 2012
Condensed Consolidated Balance Sheets
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized	200,000,000	200,000,000
Common stock, shares issued	20,100,258	16,150,163
Common stock, shares outstanding	19,820,258	16,150,163
Treasury stock, shares at cost	3,813	3,813

XML

EARNINGS PER SHARE

9 Months Ended

Sep. 30, 2013

EARNINGS PER SHARE

EARNINGS PER SHARE

9. EARNINGS PER SHARE

The basic earnings per share calculation includes no dilution and is computed by dividing income or loss attributed to common stockholders by the weighted-average number of common shares outstanding for the period. The diluted earnings per share reflects the potential dilution that could occur if stock options and warrants were exercised or converted into common stock. Potentially dilutive shares of 426,841 were excluded from the calculation of earnings per share because they were anti-dilutive due to our net loss position for the nine months ended September 30, 2013.

XML

Condensed Consolidated Statements of Cash Flows (USD $)	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012
Operating activities:
Net loss	$ (11,943,038)	$ (14,633,899)
Reconciliation of net loss to cash used in operations:
Accretion/amortization of asset retirement obligations	292,305	69,416
Depreciation and depletion	341,680	423,388
Impairment of uranium properties	683,356	1,048,400
Decrease in restoration and reclamation accrual	(1,269,663)	(1,299,806)
Stock compensation expense	299,286	373,838
Other non-cash items, net	73,875	73,932
Effect of changes in operating working capital items:
(Increase) decrease in receivables	258,532	(140,228)
Increase in prepaid and other current assets	(17,274)	(125,058)
Increase (decrease) in payables, accrued liabilities and deferred credits	(231,931)	668,089
Net cash used in operating activities	(11,512,872)	(13,541,928)
Cash flows from investing activities:
Decrease in certificates of deposit, restricted	5,481,015	167,855
Additions to uranium properties	(122,165)	(1,132,294)
Acquisition of Neutron Energy, Inc.		(3,677,133)
Net cash provided by (used in) investing activities	5,358,850	(4,641,572)
Cash flows from financing activities:
Payments on borrowings	(103,173)	(56,775)
Issuance of common stock, net	3,599,432	19,328,360
Net cash provided by financing activities	3,496,259	19,271,585
Net increase (decrease) in cash and cash equivalents	(2,657,763)	1,088,085
Cash and cash equivalents, beginning of period	4,664,596	2,890,263
Cash and cash equivalents, end of period	2,006,833	3,978,348
Non-cash transactions:
Issuance of common stock for short-term loan principal and interest payment	5,095,833
Issuance of common stock for services	291,500
Issuance of restricted stock to employees and directors	47	391
Issuance of common stock to acquire Neutron Energy, Inc.		16,650,000
Capital lease obligations		$ 106,154

XML

Condensed Consolidated Balance Sheets (USD $)	Sep. 30, 2013	Dec. 31, 2012
Current Assets:
Cash and cash equivalents	$ 2,006,833	$ 4,664,596
Prepaid and other current assets	466,970	708,228
Total Current Assets	2,473,803	5,372,824
Property, plant and equipment, at cost:
Property, plant and equipment	99,891,946	100,058,667
Less accumulated depreciation, depletion and impairment	(65,544,841)	(65,318,921)
Net property, plant and equipment	34,347,105	34,739,746
Certificates of deposit, restricted	4,010,850	9,491,865
Total Assets	40,831,758	49,604,435
Current Liabilities:
Accounts payable	397,479	1,331,888
Accrued liabilities	1,840,951	1,525,726
Note payable		5,000,000
Current portion of asset retirement obligations	502,472	1,160,378
Current portion of capital leases	19,861	112,140
Total Current Liabilities	2,760,763	9,130,132
Asset retirement obligations	3,602,252	3,337,679
Long-term debt	950,000	950,000
Long-term capital leases, less current portion	6,688	17,582
Total Liabilities	7,319,703	13,435,393
Shareholders' Equity:
Common stock, 200,000,000 shares authorized, $.001 par value; 19,820,258 and 16,150,163 shares issued and outstanding, respectively	19,824	16,154
Paid-in capital	216,620,930	207,338,549
Accumulated deficit	(183,119,281)	(171,176,243)
Less: Treasury stock (3,813 shares), at cost	(9,418)	(9,418)
Total Shareholders' Equity	33,512,055	36,169,042
Total Liabilities and Shareholders' Equity	40,831,758	49,604,435
Commitments and contingencies (Note 10)

XML

ASSET RETIREMENT OBLIGATIONS (Details) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Change in the balance of the restoration and reclamation liability
Reserve for future restoration and reclamation costs beginning of period			$ 4,498,057
Additions and changes in cash flow estimates			584,025
Costs incurred			(1,269,663)
Accretion expense	97,435	22,673	292,305	69,416
Reserve for future restoration and reclamation costs end of period	$ 4,104,724		$ 4,104,724

XML

LIQUIDITY AND GOING CONCERN (Details) (USD $)	9 Months Ended				0 Months Ended	1 Months Ended	0 Months Ended			1 Months Ended			1 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Dec. 31, 2012	Dec. 31, 2011	Oct. 21, 2013 Subsequent event	Mar. 31, 2013 Rights offering	Oct. 17, 2013 RCF Letter Agreement Secured convertible loan facility Subsequent event tranch	Oct. 14, 2013 RCF Letter Agreement Secured convertible loan facility Subsequent event	Mar. 31, 2013 RCF Rights offering	Mar. 31, 2013 RCF Rights offering Short term financing	Sep. 30, 2013 BTIG, LLC ATM Sales Agreement	Dec. 31, 2011 BTIG, LLC Maximum ATM Sales Agreement	Apr. 30, 2013 Lexon	Feb. 28, 2013 Lexon
LIQUIDITY AND GOING CONCERN
Negative cash flow from operations	$ 11,512,872	$ 13,541,928
Cash	2,006,833	3,978,348	4,664,596	2,890,263	1,300,000
Value of Shareholder Rights Offering						8,600,000
Net proceeds from sale of shares of common stock in cash	3,599,432	19,328,360				3,600,000
Short term financing repaid										5,000,000
Ownership percentage									32.80%
Restricted cash	4,010,850		9,491,865										3,600,000	9,300,000
Amount of the bonds written by the insurer														9,000,000
Required collateral as a percentage of bond amount (as a percent)														40.00%
Increase in cash													5,400,000
Aggregate offering price of the shares of common stock available to be sold under ATM Sales Agreement											9,000,000	15,000,000
Maximum borrowing capacity								15,000,000
Borrowing which is expected on or before November 15, 2013							3,000,000
Borrowing which is expected to occur on or before January 31, 2014							2,000,000
Number of additional tranches							2
Tranches available in 2014							5,000,000
Amount of cash expended	1,300,000
Amount of cash expended each month					$ 1,100,000

XML

ASSET RETIREMENT OBLIGATIONS

9 Months Ended

Sep. 30, 2013

ASSET RETIREMENT OBLIGATIONS

ASSET RETIREMENT OBLIGATIONS

8. ASSET RETIREMENT OBLIGATIONS

The following table shows the change in the balance of the restoration and reclamation liability during the nine months ended September 30, 2013:

Reserve for future restoration and reclamation costs, beginning of year	$	4,498,057
Additions and changes in cash flow estimates	584,025
Costs incurred	(1,269,663		)
Accretion expense	292,305
Reserve for future restoration and reclamation costs, end of period	$	4,104,724

XML

EARNINGS PER SHARE (Details)	9 Months Ended
	Sep. 30, 2013
EARNINGS PER SHARE
Dilutive securities (in shares)	0
Potential dilutive common stock excluded from the calculation of diluted earnings per share (in shares)	426,841

XML

RESTATEMENT (Tables)

9 Months Ended

Sep. 30, 2013

RESTATEMENT

Schedule of effects of the restatement adjustments on financial statements

Consolidated Balance Sheet

	September 30, 2013
	As Reported		Adjustment		As Restated
	$		$		$
Assets
Property, plant and equipment	108,862,877		(8,970,931	)	99,891,946
Total Assets	49,802,689		(8,970,931	)	40,831,758
Shareholders’ equity
Accumulated deficit	(174,148,350	)	(8,970,931	)	(183,119,281	)
Total shareholders’ equity	42,482,986		(8,970,931	)	33,512,055
Total liabilities and shareholders’ equity	49,802,689		(8,970,931	)	40,831,758

Consolidated Statement of Operations

	Three Months Ended September 30, 2013
	As Reported		Adjustment		As Restated
	$		$		$
Mineral property expenses	282,478		89,506		371,984
Impairment of uranium properties	769,580		(765,879	)	3,701
Total cost of uranium sales	1,793,615		(676,373	)	1,117,242
Loss from operations before corporate expenses	(1,793,615	)	676,373		(1,117,242	)
Loss from operations	(4,001,108	)	676,373		(3,324,735	)
Net loss	(3,949,264	)	676,373		(3,272,891	)
Basic and diluted net loss per common share	(0.20	)	0.04		(0.16	)

Consolidated Statement of Operations

	Nine Months Ended September 30, 2013
	As Reported		Adjustment		As Restated
	$		$		$
Mineral property expenses	1,033,838		762,475		1,796,313
Impairment of uranium properties	1,449,235		(765,879	)	683,356
Total cost of uranium sales	4,887,442		(3,404	)	4,884,038
Loss from operations before corporate expenses	(4,887,442	)	3,404		(4,884,038	)
Loss from operations	(11,753,195	)	3,404		(11,749,791	)
Net loss	(11,946,442	)	3,404		(11,943,038	)
Basic and diluted net loss per common share	(0.63	)	0.00		(0.63	)

Consolidated Statement of Cash Flows

	Nine Months Ended September 30, 2013
	As Reported		Adjustment		As Restated
	$		$		$
Net loss	(11,946,442	)	3,404		(11,943,038	)
Impairment of uranium properties	1,449,235		(765,879	)	683,356
Additions to uranium properties	(884,640	)	762,475		(122,165	)

Consolidated Statement of Operations

	Three Months Ended September 30, 2012
	As Reported		Adjustment		As Restated
	$		$		$
Mineral property expenses	12,402		969,255		981,657
Total cost of uranium sales	1,199,786		969,255		2,169,041
Loss from operations before corporate expenses	(1,199,786	)	(969,255	)	(2,169,041	)
Loss from operations	(4,235,360	)	(969,255	)	(5,204,615	)
Net loss	(4,220,914	)	(969,255	)	(5,190,169	)
Basic and diluted net loss per common share	(0.34	)	(0.08	)	(0.42	)

Consolidated Statement of Operations

	Nine Months Ended September 30, 2012
	As Reported		Adjustment		As Restated
	$		$		$
Mineral property expenses	69,861		3,145,836		3,215,697
Total cost of uranium sales	3,426,915		3,145,836		6,572,751
Loss from operations before corporate expenses	(3,426,915	)	(3,145,836	)	(6,572,751	)
Loss from operations	(11,723,018	)	(3,145,836	)	(14,868,854	)
Net loss	(11,488,063	)	(3,145,836	)	(14,633,899	)
Basic and diluted net loss per common share	(1.05	)	(0.29	)	(1.34	)

Consolidated Statement of Cash Flows

	Nine Months Ended September 30, 2012
	As Reported		Adjustment		As Restated
	$		$		$
Net loss	(11,488,063	)	(3,145,836	)	(14,633,899	)
Additions to uranium properties	(4,278,130	)	3,145,836		(1,132,294	)

XML

STOCK BASED COMPENSATION

9 Months Ended

Sep. 30, 2013

STOCK BASED COMPENSATION

STOCK BASED COMPENSATION

7. STOCK BASED COMPENSATION

Our stock based compensation programs consist of stock option and restricted stock grants made to employees and directors.

2013 Omnibus Incentive Plan

In June 2013, the Company’s stockholders and Board approved the 2013 Omnibus Incentive Plan (“2013 OIP”) that governs all future share-based awards. A total of approximately 1 million shares are available to be issued under the 2013 OIP.

Stock Compensation Expense

Stock compensation expense for the nine months ended September 30, 2013 and 2012 was $299,000 and $374,000, respectively. Stock compensation expense is recorded as a component of general and administrative expenses for each period. The Company did not recognize a tax benefit from the stock compensation expense because the Company considers it is more likely than not that the related deferred tax assets, which have been reduced by a full valuation allowance, will not be realized.

On January 16, 2013, the Company granted to a newly appointed non-employee director stock options to purchase 5,000 common shares of the Company. The fair value for this issuance was $3.30.

On March 12, 2013, the Company granted 25,000 restricted shares of the Company’s common stock to the new President and Chief Executive Officer, subject to service and performance vesting criteria over a three-year period. The fair value for this issuance was $2.73.

On March 12, 2013, the Company also granted to the new President and Chief Executive Officer stock options to purchase 55,000 common shares of the Company, subject to service and performance vesting criteria over a three-year period. The fair value for this issuance was $1.98.

On March 12, 2013, the Company granted 25,000 restricted shares of the Company’s common stock to a former executive of the Company in connection with a separation agreement signed with the executive. The Company recognized stock compensation expense for the restricted share grants of $43,000 in the first half of 2013 in connection with this issuance. In addition, the Company extended the exercise period for certain previously issued stock options for this former executive and recognized stock compensation expense for this modification of $134,000 in the first half of 2013.

On June 4, 2013, the Compensation Committee approved a grant of 100,000 shares of restricted stock units under the 2013 OIP to the President and Chief Executive Officer, subject to specific vesting criteria over a three-year period. The fair value for this issuance was $2.83.

On June 4, 2013, the Board also approved a grant of a total of 100,000 restricted stock units under the 2013 OIP to the Company’s non-employee Directors, subject to specific vesting criteria over a three-year period. The fair value for this issuance was $2.83.

On July 30, 2013, the Compensation Committee approved a grant of 80,000 shares of restricted stock units under the 2013 OIP to the Vice President-Finance and Chief Financial Officer, subject to specific vesting criteria over a three-year period. The fair value for this issuance was $4.50.

The fair value of stock options granted to employees and directors was estimated on the dates of the grants using the Black-Sholes option pricing model with the following assumptions used for the grants made during the period:

Risk free rate	1.40% - 2.16%
Expected life	5.7 — 7.8 years
Expected volatility	84% - 89%
Expected dividend yield	0.0%

The total estimated unrecognized compensation cost from the unvested stock options and restricted grants at September 30, 2013 was approximately $1,058,000, which is expected to be recognized over the weighted average vesting period of the individual grants which range from 1-3 years.

Stock Options for the Nine Months Ended September 30, 2013

The following table summarizes stock options outstanding and changes during the nine-month period ended September 30, 2013:

	Outstanding Options
	Number of Shares		Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (Years)	Aggregate Intrinsic Value
Options outstanding at January 1, 2013	317,270		$	24.62
Granted	60,000		2.85
Exercised	—		—
Canceled or forfeited	(72,791	)	25.90
Options outstanding at September 30,2013	304,479		$	20.02	4.1	$	—
Options exercisable at September 30, 2013	226,980		$	25.57	2.3	$	—

Shares available for grant under the Company’s stock option plans as of September 30, 2013 were 907,914.

Stock options outstanding and currently exercisable at September 30, 2013 are as follows:

	Outstanding Options				Options Exercisable
Stock Option Plan	Number of Options Outstanding	Weighted Average Remaining Contractual Life (in years)	Weighted Average Exercise Price		Number of Options Exercisable	Weighted Average Exercise Price
1995 Stock Incentive Plan	145,906	0.9	$	13.46	145,906	$	13.46
2004 Stock Incentive Plan	85,241	7.8	13.92		29,408	34.74
2004 Director’s Plan	73,332	6.1	40.19		51,666	54.57
	304,479	4.1	$	20.02	226,980	$	25.57

XML

BASIS OF PRESENTATION

9 Months Ended

Sep. 30, 2013

BASIS OF PRESENTATION

BASIS OF PRESENTATION

2. BASIS OF PRESENTATION

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements. The accompanying statements should be read in conjunction with the audited financial statements included in the Company’s 2012 Annual Report on Form 10-K/A. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the nine months ended September 30, 2013 are not necessarily indicative of the results that may be expected for any other period including the full year ending December 31, 2013.

XML

STOCK BASED COMPENSATION (Tables)

9 Months Ended

Sep. 30, 2013

STOCK BASED COMPENSATION

Schedule of assumptions used to estimate fair value of stock options granted to employees and directors

Risk free rate	1.40% - 2.16%
Expected life	5.7 — 7.8 years
Expected volatility	84% - 89%
Expected dividend yield	0.0%

Summary of stock options outstanding and changes during the period

	Outstanding Options
	Number of Shares		Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (Years)	Aggregate Intrinsic Value
Options outstanding at January 1, 2013	317,270		$	24.62
Granted	60,000		2.85
Exercised	—		—
Canceled or forfeited	(72,791	)	25.90
Options outstanding at September 30,2013	304,479		$	20.02	4.1	$	—
Options exercisable at September 30, 2013	226,980		$	25.57	2.3	$	—

Schedule of stock options outstanding and currently exercisable

	Outstanding Options				Options Exercisable
Stock Option Plan	Number of Options Outstanding	Weighted Average Remaining Contractual Life (in years)	Weighted Average Exercise Price		Number of Options Exercisable	Weighted Average Exercise Price
1995 Stock Incentive Plan	145,906	0.9	$	13.46	145,906	$	13.46
2004 Stock Incentive Plan	85,241	7.8	13.92		29,408	34.74
2004 Director’s Plan	73,332	6.1	40.19		51,666	54.57
	304,479	4.1	$	20.02	226,980	$	25.57

XML

COMMITMENTS AND CONTINGENCIES

9 Months Ended

Sep. 30, 2013

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES

10. COMMITMENTS AND CONTINGENCIES

In July 2013, the Company amended its uranium supply contract with Itochu Corporation (“Itochu”) to include a new sales pricing structure, new delivery dates and quantity levels. Pursuant to the amended agreement, Itochu would purchase one-half of all production from the Company’s Vasquez, Rosita or Kingsville properties up to three million pounds of U3O8. Any new production outside of those areas is not subject to the agreement. The purchase price will be based on published market prices at the time of delivery subject to a five percent discount when the market price is $56.50 per pound of U3O8 or less, or seven percent when greater than $56.50 per pound.

The Company’s mining operations are subject to federal and state regulations for the protection of the environment, including water quality regulations. These laws periodically change and generally become more restrictive. The ongoing costs of complying with such regulations have not been significant to the Company’s annual operating costs. Future mine closure and reclamation costs are provided for as each pound of uranium is produced on a unit-of-production basis. The Company reviews its reclamation obligations each year and determines the appropriate unit charge. The Company also evaluates the status of current environmental laws and their potential impact on their accrual for costs. The Company believes its operations are in compliance with current environmental regulations.

The Company is from time to time involved in various legal proceedings of a character normally incident to its business. Management believes it has meritorious defenses in all such proceedings and is not aware of any material adverse effect on the Company’s financial condition or results of operations from such proceedings.

Registration Statements

In connection with our May 2008 private placement and the March 2012 investment agreement with RCF, the Company executed registration rights agreements pursuant to which the shares issued in the private placement and under the investment agreement were registered. The registration rights agreements provide for penalties in the event the registration statements fail to remain effective. At September 30, 2013, the Company’s registration statements were and remain effective.

Employment Agreements

The Company has entered into employment agreements with the certain of the Executive Officers of the Company that provide that, in the event of a change in control, such officers will have certain rights and benefits for a period of twenty-four months following such change in control. The employment agreements provide that the executive’s base salary payments shall be made on a monthly basis for the duration of the term and any incentive payments shall be paid annually until the obligation to make such payments expires.

In March 2013, the Company entered into an Employment Agreement with the Company’s new President and Chief Executive Officer with a one-year term (subject to subsequent automatic one-year renewals). In the event his employment is terminated following a change in control, he would be entitled to two year’s base salary payable in a lump sum within 30 days after his termination date. In the event the Company terminates the Employment Agreement during its term, other than for cause or elects not to renew the Employment Agreement at the conclusion of its term, he would be entitled to one year’s base salary payable in a lump sum within 30 days after his termination date.

In June 2013, the Company entered into an Employment Agreement with the Company’s new Vice President — Finance and Chief Financial Officer with a one-year term (subject to subsequent automatic one-year renewals).  In the event his employment is terminated following a change in control, he would be entitled to one year’s base salary payable in a lump sum within 30 days after his termination date. In the event the Company terminates the Employment Agreement during its term, other than for cause or elects not to renew the Employment Agreement at the conclusion of its terms, he would be entitled to six month’s base salary payable in a lump sum within 30 days after his termination date.

XML

RESTATEMENT (Details) (USD $)	3 Months Ended		9 Months Ended			3 Months Ended		9 Months Ended		3 Months Ended		9 Months Ended		36 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012	Dec. 31, 2012	Sep. 30, 2013 As Reported	Sep. 30, 2012 As Reported	Sep. 30, 2013 As Reported	Sep. 30, 2012 As Reported	Sep. 30, 2013 Adjustment	Sep. 30, 2012 Adjustment	Sep. 30, 2013 Adjustment	Sep. 30, 2012 Adjustment	Dec. 31, 2012 Adjustments to property expenditures Adjustment
Cumulative adjustment to mineral property expenditures														$ 8,974,000
Assets
Property, plant and equipment	99,891,946		99,891,946		100,058,667	108,862,877		108,862,877		(8,970,931)		(8,970,931)
Total Assets	40,831,758		40,831,758		49,604,435	49,802,689		49,802,689		(8,970,931)		(8,970,931)
Shareholders' equity
Accumulated deficit	(183,119,281)		(183,119,281)		(171,176,243)	(174,148,350)		(174,148,350)		(8,970,931)		(8,970,931)
Total shareholders' equity	33,512,055		33,512,055		36,169,042	42,482,986		42,482,986		(8,970,931)		(8,970,931)
Total liabilities and shareholders' equity	40,831,758		40,831,758		49,604,435	49,802,689		49,802,689		(8,970,931)		(8,970,931)
Consolidated Statement of Operations
Mineral property expenses	371,984	981,657	1,796,313	3,215,697		282,478	12,402	1,033,838	69,861	89,506	969,255	762,475	3,145,836
Impairment of uranium properties	3,701	296,628	683,356	1,048,400		769,580		1,449,235		(765,879)		(765,879)
Total cost of uranium sales	1,117,242	2,169,041	4,884,038	6,572,751		1,793,615	1,199,786	4,887,442	3,426,915	(676,373)	969,255	(3,404)	3,145,836
Loss from operations before corporate expenses	(1,117,242)	(2,169,041)	(4,884,038)	(6,572,751)		(1,793,615)	(1,199,786)	(4,887,442)	(3,426,915)	676,373	(969,255)	3,404	(3,145,836)
Loss from operations	(3,324,735)	(5,204,615)	(11,749,791)	(14,868,854)		(4,001,108)	(4,235,360)	(11,753,195)	(11,723,018)	676,373	(969,255)	3,404	(3,145,836)
Net Loss	(3,272,891)	(5,190,169)	(11,943,038)	(14,633,899)		(3,949,264)	(4,220,914)	(11,946,442)	(11,488,063)	676,373	(969,255)	3,404	(3,145,836)
Basic and diluted net loss per common share (in dollars per share)	$ (0.16)	$ (0.42)	$ (0.63)	$ (1.34)		$ (0.20)	$ (0.34)	$ (0.63)	$ (1.05)	$ 0.04	$ (0.08)	$ 0.00	$ (0.29)
Consolidated Statement of Cash Flows
Net Loss	(3,272,891)	(5,190,169)	(11,943,038)	(14,633,899)		(3,949,264)	(4,220,914)	(11,946,442)	(11,488,063)	676,373	(969,255)	3,404	(3,145,836)
Impairment of uranium properties	3,701	296,628	683,356	1,048,400		769,580		1,449,235		(765,879)		(765,879)
Additions to uranium properties			$ (122,165)	$ (1,132,294)				$ (884,640)	$ (4,278,130)			$ 762,475	$ 3,145,836

XML

ASSET RETIREMENT OBLIGATIONS (Tables)

9 Months Ended

Sep. 30, 2013

ASSET RETIREMENT OBLIGATIONS

Schedule of change in the balance of the restoration and reclamation liability

Reserve for future restoration and reclamation costs, beginning of year	$	4,498,057
Additions and changes in cash flow estimates	584,025
Costs incurred	(1,269,663		)
Accretion expense	292,305
Reserve for future restoration and reclamation costs, end of period	$	4,104,724

XML

Document and Entity Information	9 Months Ended
	Sep. 30, 2013	Oct. 28, 2013
Document and Entity Information
Entity Registrant Name	URANIUM RESOURCES INC /DE/
Entity Central Index Key	0000839470
Document Type	10-Q
Document Period End Date	Sep. 30, 2013
Amendment Flag	true
Amendment Description	As previously disclosed in a Current Report on Form 8-K filed on November 19, 2013, Uranium Resources, Inc. (the “Company,” “URI,” “we,” “us” or “our”) historically capitalized development costs after confirmation of the existence of a commercially minable uranium deposit. After discussions with the Staff of the United States Securities and Exchange Commission (the “SEC”), URI management determined that the Company’s capitalization practices were not in conformance with the SEC’s Industry Guide 7, which allows capitalization of development costs only after proven or probable reserves have been declared. This Amendment No. 1 on Form 10-Q/A (the “Amendment” or “Form 10-Q/A”) amends and restates the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2013, as originally filed with the SEC on October 28, 2013 (the “Original Form 10-Q”). This Amendment amends and restates the Company’s consolidated financial statements and related disclosures as of September 30, 2013 and for the three and nine months ended September 30, 2013 and 2012 by reclassifying costs from property, plant and equipment to mineral property expenses. The impact of the restatement is more fully described in Note 3 to the consolidated financial statements contained in this Amendment. Concurrently with the filing of this Amendment, the Company is also filing Amendment No. 1 to its Annual Report on Form 10-K for the year ended December 31, 2012 to amend and restate the Company’s consolidated financial statements and related disclosures as of December 31, 2011 and 2012 and for the years ended December 31, 2010, 2011 and 2012. As a result of the restatement, management has re-evaluated and amended its conclusions regarding the Company’s disclosure controls and procedures and internal control over financial reporting as contained in Item 4 of Part I. In addition, URI management has also determined, consistent with Industry Guide 7, to disclose mineralized material in terms of tons and grade only in its filings with the SEC. Accordingly, the Company will no longer disclose pounds of mineralized uranium material contained in the ground, and this Amendment removes all such disclosure. This Amendment also corrects an error in the number of shares of common stock outstanding as of September 30, 2013, as reflected in the consolidated financial statements contained in this Amendment, and as of October 28, 2013, as shown on the cover page. The correct number is 19,820,258 shares, as indicated in the consolidated financial statements and on the cover page of this Amendment. The following items of the Original Form 10-Q have been modified or revised in this Form 10-Q/A to reflect the restatement and other changes identified above: the cover page; Part I, Item 1. “Financial Statements”; Part I, Item 2. “Management’s Discussion and Analysis of Financial Condition and Results of Operations”; and Part I, Item 4. “Controls and Procedures”. The Company’s principal executive officer and principal financial officer have also provided currently dated certifications pursuant to Sections 302 and 906 of the Sarbanes-Oxley Act of 2002 in connection with this Amendment. This Amendment sets forth the Original Form 10-Q in its entirety, except as required to reflect the effects of the restatement and other changes identified above. Except for disclosures affected by the restatement and other changes, this Amendment speaks as of the original filing date of the Original Form 10-Q and does not modify or update other disclosures in the Original Form 10-Q, including the nature and character of such disclosures, to reflect events occurring or items discovered after the original filing date of the Original Form 10-Q. This Amendment should be read in conjunction with the Company’s amended Annual Report on Form 10-K/A for the year ended December 31, 2012 and all filings made with the SEC subsequent to the original filing date of the Form 10-K, together with any amendments to those filings, including the Company’s amended Quarterly Reports on Form 10-Q/A for the quarterly periods ended March 31, 2013 and June 30, 2013, as filed with the SEC on December 17, 2013.
Current Fiscal Year End Date	--12-31
Entity Current Reporting Status	Yes
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		19,820,258
Document Fiscal Year Focus	2013
Document Fiscal Period Focus	Q3

XML

DESCRIPTION OF BUSINESS (Details)	9 Months Ended
	Sep. 30, 2013 item
DESCRIPTION OF BUSINESS
Number of licensed processing facilities	2
Maximum uranium entity licensed to produce (in pounds per year)	3,000,000
Period over which properties were acquired	20 years
Number of properties currently in production	0